pulmonari
patholog
includ
larg
spectrum
neoplast
nonneoplast
diseas
affect
lung
mani
result
unusu
relationship
lung
outsid
world
everi
breath
human
take
bring
outsid
world
bodi
form
infecti
agent
organ
inorgan
particl
noxiou
agent
type
although
lung
mani
defens
mechan
protect
insult
infal
lung
patholog
aris
damag
lung
particularli
import
given
role
lung
surviv
organ
impair
lung
function
widespread
effect
throughout
bodi
sinc
organ
depend
lung
oxygen
need
pulmonari
patholog
catalog
chang
lung
tissu
mechan
occur
follow
review
lung
patholog
current
state
knowledg
pathogenesi
diseas
believ
clear
understand
morpholog
mechan
requir
develop
new
therapi
prevent
measur
lung
cancer
major
caus
morbid
mortal
throughout
world
recent
estim
avail
surveil
epidemiolog
end
result
seer
program
nation
cancer
institut
peopl
unit
state
diagnos
cancer
lung
bronchu
die
due
diseas
howev
past
decad
incid
mortal
rate
begun
move
posit
direct
particularli
men
overal
men
show
declin
lung
cancer
incid
women
although
lung
cancer
rate
grew
stabil
similarli
cancer
death
rate
due
lung
cancer
declin
men
slow
women
although
women
lung
cancer
death
rate
increas
sinc
rate
increas
slow
annual
trend
parallel
chang
preval
tobacco
smoke
import
risk
factor
develop
lung
cancer
given
tremend
societ
individu
impact
diseas
surpris
molecular
biolog
lung
cancer
major
focu
investig
elucid
molecular
pathogenesi
neoplasm
progress
significantli
offer
insight
new
target
therapi
predictor
prognosi
therapeut
respons
recognit
precursor
lesion
type
lung
cancer
facilit
expand
understand
earli
molecular
chang
involv
carcinogenesi
world
health
organ
classif
scheme
wide
use
system
classif
neoplasm
tabl
although
numer
histolog
type
subtyp
lung
cancer
common
malign
epitheli
tumor
group
categori
nonsmal
cell
lung
cancer
nsclc
small
cell
carcinoma
sclc
nsclc
includ
adenocarcinoma
ac
squamou
cell
carcinoma
sqcc
larg
cell
carcinoma
adenosquam
carcinoma
sarcomatoid
carcinoma
sclc
includ
case
pure
combin
small
cell
carcinoma
common
pulmonari
symptom
associ
tumor
includ
cough
short
breath
chest
pain
tight
hemoptysi
cough
blood
sinc
tumor
caus
airway
obstruct
predispos
pneumonia
import
clue
exist
tumor
patient
constitut
symptom
includ
fever
weight
loss
malais
neoplasm
declar
symptom
relat
local
invas
adjac
structur
chest
wall
nerv
superior
vena
cava
esophagu
heart
sclc
known
earli
widespread
metastasi
therefor
particularli
prone
discov
present
metastas
distant
site
tumor
discov
due
pathophysiolog
chang
trigger
releas
solubl
substanc
tumor
cell
endocrin
syndrom
due
elabor
hormon
well
recogn
includ
cush
syndrom
syndrom
inappropri
antidiuret
hormon
hypercalcemia
carcinoid
syndrom
gynecomastia
other
hypercoagul
commonli
occur
lung
cancer
lead
manifest
venou
thrombosi
nonbacteri
thrombot
endocard
dissemin
intravascular
coagul
hematolog
chang
includ
anemia
granulocytosi
eosinophilia
abnorm
paraneoplast
syndrom
club
finger
myasthen
syndrom
dermatomyositispolymyos
transvers
myeliti
note
subset
patient
lung
cancer
suspect
evalu
patient
includ
thorough
clinic
radiolog
laboratori
assess
collect
tissu
cytolog
sampl
establish
patholog
diagnosi
malign
classifi
tumor
type
fiberopt
bronchoscopi
often
perform
collect
sampl
diagnosi
sampl
type
includ
transbronchi
endobronchi
biopsi
bronchial
brush
bronchial
wash
bronchoalveolar
lavag
sampl
transbronchi
needl
aspir
submiss
sputum
sampl
cytolog
malign
epitheli
tumor
examin
provid
diagnosi
case
particularli
central
locat
tumor
sqcc
sclc
tumor
aris
peripher
locat
also
sampl
mani
case
fine
needl
aspir
core
needl
biopsi
perform
radiolog
guidanc
pleural
effus
present
combin
lung
parenchym
tumor
analysi
pleural
fluid
cytolog
often
allow
one
establish
diagnosi
pleural
biopsi
mediastinoscopi
biopsi
wedg
biopsi
also
perform
depend
clinic
radiolog
find
tumor
appar
distant
metastasi
biopsi
metastasi
focu
establish
patholog
diagnosi
determin
stage
tumor
prognosi
lung
cancer
close
relat
tumor
stage
nsclc
american
joint
commiss
cancer
tnm
stage
system
wide
use
tabl
sclc
diseas
classifi
limit
restrict
one
hemithorax
extens
overal
lung
cancer
surviv
men
women
import
factor
lead
rel
poor
surviv
late
stage
mani
lung
cancer
diagnos
inform
seer
databas
indic
patient
diagnos
local
region
distant
unstag
diseas
respect
correspond
surviv
rate
surviv
rate
patient
nsclc
treatment
depend
stage
comorbid
condit
surgic
resect
prefer
approach
treatment
local
nsclc
provid
medic
contraind
oper
intervent
lobectomi
extens
resect
depend
tumor
extent
usual
recommend
rather
lesser
surgeri
unless
comorbid
condit
preclud
procedur
tumor
cm
greatest
dimens
surround
lung
viscer
pleura
without
bronchoscop
evid
invas
proxim
lobar
bronchu
tumor
follow
featur
size
extent
cm
greatest
dimens
involv
main
bronchu
cm
distal
carina
invad
viscer
pleura
associ
atelectasi
obstruct
pneumon
extend
hilar
region
involv
entir
lung
tumor
size
directli
invad
chest
wall
diaphragm
mediastin
pleura
pariet
pericardium
lie
cm
distal
carina
without
involv
carina
associ
atelectasi
obstruct
pneumon
entir
lung
tumor
size
invad
mediastinum
heart
great
vessel
trachea
esophagu
vertebr
bodi
carina
separ
tumor
nodul
lobe
associ
malign
pleural
effus
region
lymph
node
n
nx
region
lymph
node
assess
region
lymph
node
metastasi
metastasi
ipsilater
peribronchi
andor
ipsilater
hilar
lymph
node
includ
intrapulmonari
node
involv
direct
extens
primari
tumor
metastasi
ipsilater
mediastin
andor
subcarin
lymph
node
metastasi
contralater
mediastin
contralater
hilar
ipsilater
contralater
scalen
supraclavicular
lymph
node
mx
distant
metastasi
assess
distant
metastasi
distant
metastasi
includ
separ
tumor
nodul
differ
lobe
occult
stage
ti
stage
ia
stage
ib
stage
iia
stage
iib
stage
iiia
stage
iiib
intraop
mediastin
lymph
node
sampl
dissect
also
recommend
accur
patholog
stage
determin
therapi
subset
patient
also
benefit
chemotherapi
radiotherapi
advanc
nsclc
sclc
chemotherapi
radiotherapi
primari
treatment
modal
rare
patient
limitedstag
sclc
consid
surgic
resect
cur
intent
develop
lung
cancer
occur
multipl
complex
stepwis
genet
epigenet
chang
involv
allel
loss
chromosom
instabl
imbal
mutat
tumor
suppressor
gene
tsg
domin
oncogen
epigenet
gene
silenc
promot
hypermethyl
aberr
express
gene
particip
control
cell
prolifer
apoptosi
similar
well
typespecif
differ
molecular
alter
nsclc
sclc
sqcc
ac
oncogen
play
part
pathogenesi
lung
cancer
includ
myc
kra
predominantli
ac
cyclin
erbb
famili
gene
egfr
epiderm
growth
factor
receptor
predominantli
ac
predominantli
ac
also
lung
cancer
often
display
abnorm
involv
tsg
includ
rb
new
candid
tsg
short
arm
chromosom
fhit
research
advanc
list
continu
grow
knowledg
expand
role
gene
carcinogenesi
tumor
behavior
new
target
therapeut
agent
design
treat
diseas
figur
tabl
mani
agent
investig
cancer
chromosom
region
harbor
tsg
oncogen
often
delet
amplifi
allel
loss
involv
loci
consist
featur
lung
cancer
pathogenesi
wistuba
et
al
report
allel
loss
often
multipl
discontinu
lung
cancer
studi
precursor
lesion
larger
segment
allel
loss
note
sclc
sqcc
ac
preneoplasticpreinvas
lesion
allel
loss
delet
region
lung
cancer
normal
reneoplasticpreinvas
lesion
associ
lung
cancer
normal
mildli
abnorm
preneoplast
preinvas
lesion
found
smoker
without
lung
cancer
loss
seen
sampl
peopl
never
smoke
delet
also
frequent
earli
event
pathogenesi
lung
carcinoma
common
alter
includ
loh
allel
loss
frequent
sqcc
ac
includ
delet
rb
sever
region
recent
studi
util
bacteri
artifici
chromosom
array
perform
highresolut
whole
genom
profil
sqcc
ac
cell
line
show
region
frequent
amplif
share
type
tumor
includ
chromosom
common
region
delet
includ
chromosom
chromosom
howev
ac
appear
higher
frequenc
delet
chromosom
chromosom
sqcc
possess
small
region
amplif
chromosom
seen
sqcc
chromosom
arm
frequent
delet
ac
amplifi
sqcc
cell
line
type
tumor
show
delet
chromosom
arm
frequent
sqcc
cell
line
amplif
chromosom
frequent
ac
amplif
chromosom
common
type
tumor
show
frequent
alter
sqcc
line
ac
line
inactiv
recess
oncogen
believ
occur
twostag
process
suggest
first
allel
inactiv
occur
often
via
point
mutat
second
allel
later
inactiv
chromosom
delet
transloc
alter
methyl
gene
promot
region
inactiv
mutat
tsg
encod
protein
frequent
mutat
lung
cancer
mutat
found
nsclc
sclc
larg
attribut
direct
dna
damag
cigarett
smoke
carcinogen
mutat
pattern
show
preval
g
transvers
smoker
lung
cancer
versu
lung
cancer
nonsmok
protein
transcript
factor
key
regul
cell
cycl
progress
cellular
signal
induc
dna
damag
oncogen
express
stimuli
trigger
respons
includ
initi
cell
cycl
arrest
apoptosi
differenti
dna
repair
loss
function
tumor
cell
result
inappropri
progress
dysregul
cell
cycl
checkpoint
permit
inappropri
surviv
genet
damag
cell
cyclin
pathway
play
central
role
control
phase
transit
cell
cycl
anoth
import
tumor
suppressor
pathway
often
disrupt
lung
cancer
interfac
pathway
arf
thirti
percent
nsclc
contain
mutat
includ
homozyg
delet
point
mutat
epigenet
alter
lead
inactiv
almost
sclc
smaller
number
nsclc
hand
display
loss
rb
express
mutat
mechan
usual
respons
includ
delet
nonsens
mutat
splice
abnorm
lead
truncat
rb
protein
lead
hypophosphoryl
rb
protein
caus
arrest
cell
phase
activ
hypophosphoryl
form
rb
regul
cellular
protein
includ
transcript
factor
essenti
progress
phase
transit
loss
protein
increas
complex
cyclin
cyclin
lead
hyperphosphoryl
rb
result
evas
cell
cycl
arrest
progress
phase
cell
cycl
progress
inhibit
inhibit
cyclin
complex
nsclc
lack
detect
alter
rb
may
abnorm
cyclin
caus
inactiv
rb
pathway
figur
provid
overview
retinoblastoma
rb
pathway
show
complex
interact
compon
epigenet
alter
hypermethyl
cpg
island
tsg
also
frequent
occurr
pulmonari
carcinogenesi
methyl
profil
nsclc
show
relationship
smoke
exposur
histolog
type
geographi
methyl
rate
apc
mean
methyl
index
mi
reflect
overal
methyl
statu
current
former
smoker
significantli
higher
never
smoker
mean
mi
tumor
highest
current
smoker
methyl
rate
apc
rarbeta
significantli
higher
ac
sqcc
methyl
rate
mgmt
case
unit
state
australia
significantli
exceed
japanes
taiwanes
case
signific
genderrel
differ
methyl
pattern
found
protooncogen
activ
growth
factor
signal
import
pulmonari
carcinogenesi
tyrosin
kinas
epiderm
growth
factor
receptor
egfr
frequent
mutat
nsclc
particularli
ac
mutat
statu
import
determin
respons
tyrosin
kinas
inhibitor
relat
pathway
phosphoinositid
aktmammalian
target
rapamycin
mtor
pathway
frequent
deregul
pulmonari
carcinogenesi
review
marinov
et
al
pathway
report
mediat
effect
sever
tyrosin
kinas
receptor
includ
egfr
cmet
ckit
igfir
prolifer
surviv
nsclc
sclc
clinic
trial
ongo
investig
efficaci
mtor
inhibitor
rapamycin
analogu
lung
cancer
anoth
relat
receptor
tyrosin
kinas
upregul
approxim
nsclc
unlik
situat
breast
cancer
treatment
antibodi
trastuzumab
seem
yield
compar
benefit
nsclc
use
alon
combin
chemotherapi
point
mutat
ra
famili
protooncogen
often
kra
codon
detect
lung
ac
nsclc
although
farnesyl
transferas
inhibitor
prevent
ra
signal
agent
shown
signific
activ
singleag
therapi
untreat
nsclc
relaps
sclc
myc
famili
gene
myc
mycn
mycl
play
role
cell
cycl
regul
prolifer
dna
synthesi
frequent
activ
sclc
nsclc
either
gene
amplif
transcript
dysregul
vascular
endotheli
growth
factor
vegf
homodimer
glycoprotein
overexpress
mani
lung
cancer
directli
stimul
endotheli
cell
prolifer
promot
endotheli
cell
surviv
newli
form
vessel
induc
proteas
involv
degrad
extracellular
matrix
need
endotheli
cell
migrat
angiogen
effect
mediat
three
receptor
ligand
bind
lead
tyrosin
kinas
activ
activ
signal
pathway
requir
angiogenesi
monoclon
antibodi
vegf
bevacizumab
tyrosin
kinas
inhibitor
vegfr
develop
show
promis
treatment
nsclc
phase
iii
trial
bevacizumab
show
significantli
improv
overal
progressionfre
surviv
agent
use
combin
standard
firstlin
chemotherapi
patient
advanc
nsclc
sever
smallmolecul
vegfr
tyrosin
kinas
inhibitor
yield
favor
result
phase
ii
trial
nsclc
microrna
recent
discov
class
nonproteincod
endogen
small
rna
regul
gene
express
translat
repress
mrna
cleavag
mrna
decay
initi
mirnaguid
rapid
deadenyl
microrna
suggest
play
role
carcinogenesi
function
oncogen
tumor
suppressor
neg
regul
tsg
andor
gene
control
cell
differenti
apoptosi
investig
therapeut
potenti
microrna
also
way
version
classif
scheme
ac
defin
malign
epitheli
tumour
glandular
differenti
mucin
product
show
acinar
papillari
bronchioloalveolar
solid
mucin
growth
pattern
mixtur
pattern
ac
becom
frequent
histolog
type
lung
cancer
part
world
occur
primarili
smoker
repres
common
type
lung
cancer
peopl
never
smoke
women
small
subset
tumor
aris
patient
local
scar
diffus
fibros
lung
diseas
asbestosi
interstiti
pneumonia
associ
scleroderma
neoplasm
usual
aris
peripheri
lung
like
invad
pleura
chest
wall
histolog
type
lung
cancer
radiolog
studi
show
one
nodul
groundglass
opac
mix
solid
groundglass
lesion
gross
examin
neoplasm
often
solitari
graywhit
nodul
mass
sometim
necrosi
cavit
pucker
overli
pleura
mucinproduc
tumor
glisten
gelatin
appear
present
includ
pattern
consolid
resembl
pneumonia
usual
bronchioloalveolar
carcinoma
figur
multipl
nodul
diffus
interstiti
widen
due
lymphangit
spread
endobronchi
lesion
submucos
infiltr
diffus
viscer
pleural
infiltr
thicken
resembl
mesothelioma
common
histolog
pattern
display
ac
includ
acinar
figur
chapter
molecular
basi
pulmonari
diseas
mixtur
pattern
frequent
less
common
histolog
subtyp
includ
fetal
ac
mucin
colloid
ac
mucin
cystadenocarcinoma
signet
ring
ac
clear
cell
ac
ac
usual
exhibit
differenti
toward
clara
cell
type
ii
pneumocyt
less
often
goblet
cell
manifest
rang
differenti
extend
welldifferenti
tumor
extens
gland
format
littl
cytoatypia
poorli
differenti
solid
tumor
categor
ac
unless
one
order
mucin
stain
figur
howev
exampl
includ
readili
identifi
gland
invas
reflect
presenc
neoplast
gland
infiltr
stroma
pleura
stimul
fibroblast
desmoplast
respons
figur
cell
lumen
blood
vessel
lymphat
recent
year
atyp
adenomat
hyperplasia
aah
recogn
precursor
lesion
peripher
pulmonari
ac
lesion
defin
local
prolifer
mild
moder
atyp
cell
line
involv
alveoli
sometim
respiratori
bronchiol
result
focal
lesion
peripher
part
iv
molecular
patholog
human
diseas
alveol
lung
usual
less
mm
diamet
gener
absenc
underli
interstiti
inflamm
fibrosi
figur
aah
exist
histolog
continuum
bronchioloalveolar
carcinoma
bac
defin
situ
noninvas
form
ac
neoplast
cell
grow
along
alveolar
septa
lepid
growth
without
invas
stroma
vasculatur
figur
figur
bac
exceed
cm
diamet
consist
cell
greater
degre
cytoatypia
aah
although
aah
found
approxim
patient
without
lung
cancer
autopsi
report
lung
resect
specimen
type
primari
lung
cancer
lung
resect
specimen
ac
progenitor
cell
bac
aah
believ
epitheli
cell
locat
junction
termin
bronchiol
alveolu
term
bronchioalveolar
stem
cell
recent
publish
largescal
studi
primari
lung
ac
use
dens
singl
nucleotid
polymorph
array
describ
significantli
recurr
copynumb
alter
tumor
tabl
twentysix
autosom
chromosom
arm
show
consist
largescal
copynumb
gain
loss
recurr
focal
event
includ
amplif
homozyg
delet
found
although
alter
involv
region
known
harbor
protooncogen
tsg
gene
remain
identifi
region
affect
amplif
chromosom
common
event
note
found
sampl
region
includ
encod
lineagespecif
transcript
factor
thyroid
transcript
activ
transcript
target
gene
includ
surfact
protein
may
import
protooncogen
involv
signific
fraction
lung
ac
immunohistochem
stain
perform
detect
express
factor
lung
adenocarcinoma
aid
determin
lung
site
origin
tumor
figur
addit
work
use
small
interf
rna
sirna
mediat
knockdown
gene
lung
cancer
cell
line
amplif
led
reduct
tumor
cell
prolifer
decreas
cell
cycl
progress
increas
apoptosi
suggest
gene
amplif
overexpress
contribut
lung
cancer
cell
prolifer
rate
surviv
egfr
kra
mutat
mutual
exclus
mutat
event
ac
lung
suggest
exist
two
independ
oncogen
pathway
egfr
receptor
tyrosin
kinas
whose
activ
ligand
bind
lead
activ
cell
signal
pathway
rasmitogenactiv
protein
kinas
mapk
turn
propag
signal
prolifer
block
apoptosi
differenti
motil
invas
adhes
tumoracquir
mutat
tyrosin
kinas
domain
egfr
often
associ
gene
amplif
found
approxim
nsclc
unit
state
associ
ac
histolog
neversmok
statu
east
asian
ethnic
femal
gender
egfr
mutat
frequent
infram
delet
exon
singl
missens
mutat
exon
infram
duplicationsinsert
exon
occasion
missens
mutat
doubl
mutat
also
detect
egfr
mutat
invers
correl
methyl
gene
sparc
secret
protein
acid
rich
cystein
extracellular
glycoprotein
associ
regul
cell
adhes
growth
egfr
statu
import
predictor
respons
egfr
kinas
inhibitor
patient
egfr
mutat
like
signific
respons
egfr
tyrosin
kinas
inhibitor
therapi
egfr
amplif
protein
overexpress
report
correl
surviv
egfr
tyrosin
kinas
inhibitor
therapi
kra
member
ra
famili
protein
function
signal
transduc
cell
membranebas
growth
factor
signal
mapk
pathway
kra
mutat
associ
smoke
male
gender
poorli
differenti
tumor
also
known
member
egfr
famili
receptor
tyrosin
kinas
mutat
less
nsclc
occur
tumor
egfr
kra
mutat
mutat
infram
insert
exon
significantli
frequent
ac
never
smoker
asian
ethnic
women
similar
egfr
mutat
alter
dna
methyl
appear
import
epigenet
chang
cancer
contribut
chromosom
instabl
global
hypomethyl
aberr
gene
express
alter
methyl
level
promot
cpg
island
lesion
defin
precursor
lesion
peripher
pulmonari
adenocarcinoma
consist
wellcircumscrib
nodul
measur
sever
millimet
diamet
alveolar
septa
line
mildli
moder
atyp
cell
epigenet
differ
exist
egfrmedi
krasmedi
tumorigenesi
may
interact
genet
chang
recent
studi
show
probabl
egfr
mutat
significantli
lower
among
methyl
without
methyl
index
significantli
lower
egfr
mutant
case
wildtyp
contrast
kra
mutat
significantli
higher
methyl
case
unmethyl
case
methyl
index
higher
kra
mutant
case
wildtyp
sqcc
defin
malign
epitheli
tumour
show
keratin
andor
intercellular
bridg
aris
bronchial
epithelium
classif
scheme
common
histolog
type
nsclc
close
link
cigarett
smoke
patient
tumor
aris
mainstem
lobar
segment
bronchu
produc
central
mass
imag
known
tumor
suppressor
gene
protooncogen
defin
found
either
cgp
evid
one
known
protooncogen
region
one
list
prioriti
list
order
known
lung
adenocarcinoma
mutat
known
lung
cancer
mutat
known
mutat
cosmic
frequenc
list
cgp
censu
myc
near
within
peak
region
ksingl
gene
delet
previous
seen
studi
provid
new
mutat
well
part
iv
molecular
patholog
human
diseas
studi
mani
tumor
endobronchi
compon
caus
airway
obstruct
lead
postobstruct
pneumonia
atelectasi
bronchiectasi
infrequ
pneumonia
prompt
evalu
patient
lead
discoveri
tumor
less
often
sqcc
develop
peripheri
lung
gross
examin
reveal
tan
gray
mass
usual
aris
larg
bronchu
often
includ
endobronchi
compon
figur
figur
partial
complet
airway
obstruct
associ
chang
pneumonia
bronchiti
abscess
bronchiectasi
atelectasi
necrosi
cavit
common
tumor
involv
hilar
lymph
node
tangray
tumor
visibl
resect
specimen
microscop
key
featur
tumor
keratin
sometim
format
keratin
pearl
intercellular
bridg
figur
true
ac
degre
differenti
tumor
vari
well
differenti
case
abund
keratin
intercellular
bridg
littl
cytoatypia
poorli
differenti
case
keratin
intercellular
bridg
quit
inconspicu
tumor
consist
sheet
larg
atyp
cell
mark
cytoatypia
frequent
mitos
howev
case
fall
toward
middl
spectrum
invas
reflect
presenc
irregular
nest
sheet
cell
infiltr
tissu
stimul
fibroblast
respons
cell
insid
vascular
lymphat
space
invas
sqcc
often
accompani
sqcc
situ
dysplasia
precursor
lesion
lesion
aris
bronchi
may
contigu
invas
tumor
exist
one
separ
foci
precursor
lesion
also
observ
without
coexist
invas
carcinoma
like
sqcc
tobacco
smoke
main
predispos
factor
sqcc
situ
dysplasia
unlik
invas
sqcc
howev
lesion
invasivethey
extend
basement
membran
bronchial
epithelium
grossli
may
invis
appear
flat
tan
red
discolor
bronchial
mucosa
tan
wartlik
excresc
microscop
lesion
encompass
chapter
molecular
basi
pulmonari
diseas
rang
squamou
chang
includ
alter
thick
bronchial
epithelium
matur
progress
squamou
differenti
cell
size
nuclear
characterist
figur
figur
dysplasia
increas
mild
moder
sever
epithelium
thicken
matur
increasingli
impair
basilar
zone
expand
epitheli
cell
crowd
intermedi
zone
shrink
reduc
flatten
superfici
squamou
cell
cell
size
pleomorph
anisocytosi
usual
increas
coarsen
chromatin
appear
nucleoli
nuclear
angul
fold
carcinoma
situ
although
epithelium
may
may
thicken
cell
size
may
small
medium
larg
minim
matur
base
superfici
aspect
atyp
nuclear
featur
present
throughout
entir
thick
epithelium
mitos
appear
lower
third
mild
moder
dysplasia
lower
twothird
sever
dysplasia
throughout
full
thick
epithelium
carcinoma
situ
basal
cell
bronchial
epithelium
believ
repres
progenitor
cell
invas
sqcc
sequenc
event
lead
sqcc
believ
includ
basal
cell
hyperplasia
squamou
metaplasia
squamou
dysplasia
carcinoma
situ
invas
sqcc
figur
regress
lesion
preced
invas
sqcc
occur
particularli
earlier
lesion
howev
sever
dysplasia
carcinoma
situ
associ
significantli
increas
probabl
develop
invas
sqcc
patient
follow
time
surveil
bronchoscopi
wistuba
colleagu
evalu
sqcc
precursor
lesion
loss
heterozygos
loh
chromosom
region
rb
part
iv
molecular
patholog
human
diseas
frequent
delet
lung
cancer
found
multipl
sequenti
occur
allelespecif
molecular
chang
separ
appar
clonal
independ
foci
earli
pathogenesi
sqcc
lung
suggest
field
cancer
effect
observ
clone
cell
allel
loss
one
region
percent
histolog
normal
epithelium
specimen
hyperplasia
metaplasia
increas
frequenc
loh
within
clone
increas
histopatholog
lesion
sever
frequent
earliest
region
allel
loss
increas
size
delet
progress
histolog
chang
allel
loss
mani
histolog
advanc
lesion
dysplasia
ci
overview
sequenti
molecular
event
lead
invas
sqcc
shown
figur
larg
cell
carcinoma
undifferenti
nsclc
without
light
microscop
evid
squamou
glandular
differenti
although
squamou
glandular
featur
may
detect
ultrastructur
examin
figur
histolog
subtyp
larg
cell
carcinoma
includ
larg
cell
neuroendocrin
carcinoma
lcnec
combin
lcnec
basaloid
carcinoma
lymphoepitheliomalik
carcinoma
clear
cell
carcinoma
larg
cell
carcinoma
rhabdoid
phenotyp
clinic
sign
symptom
resembl
type
nsclc
tumor
develop
peripher
lung
mass
except
basaloid
carcinoma
usual
form
central
locat
mass
histolog
larg
cell
carcinoma
consist
sheet
nest
larg
cell
vesicular
nuclei
promin
nucleoli
moder
abund
amount
cytoplasm
lcnec
demonstr
neuroendocrin
architectur
featur
immunohistochem
ultrastructur
evid
neuroendocrin
differenti
basaloid
carcinoma
display
nest
small
monomorph
round
fusiform
tumor
cell
littl
cytoplasm
numer
mitos
comedotyp
necrosi
hyalin
mucoid
stromal
degener
clear
cell
carcinoma
consist
larg
tumor
cell
clear
cytoplasm
precursor
lesion
current
recogn
subtyp
larg
cell
carcinoma
howev
basaloid
carcinoma
associ
squamou
dysplasia
onethird
case
larg
cell
carcinoma
poorli
differenti
carcinoma
demonstr
featur
ac
frequent
sqcc
neuroendocrin
differenti
examin
immunohistochemistri
electron
microscopi
molecular
method
tumor
often
demonstr
loss
gain
close
resembl
ac
histolog
type
lung
cancer
common
molecular
abnorm
includ
mutat
cmyc
amplif
promot
hypermethyl
kra
mutat
less
common
egfr
tyrosin
kinas
domain
mutat
characterist
larg
cell
carcinoma
egfrviii
delet
mutat
extracellular
domain
egfr
uncommon
major
categori
pulmonari
neuroendocrin
ne
neoplasm
includ
small
cell
carcinoma
sclc
larg
cell
neuroendocrin
carcinoma
lcnec
typic
carcinoid
atyp
carcinoid
sclc
lcnec
highgrad
carcinoma
typic
carcinoid
lowgrad
malign
neoplasm
atyp
carcinoid
occupi
intermedi
posit
spectrum
biolog
aggress
one
larg
seri
surviv
rate
typic
carcinoid
atyp
carcinoid
lcnec
sclc
respect
light
microscopi
tumor
display
ne
architectur
featur
includ
organoid
nest
trabecular
arrang
rosett
format
palisad
pattern
promin
carcinoid
lcnec
may
may
visibl
individu
sclc
typic
carcinoid
contain
fewer
mitos
per
mm
hpf
lack
necrosi
figur
atyp
carcinoid
show
mitos
per
mm
hpf
necrosi
often
punctat
sclc
consist
small
undifferenti
tumor
cell
scant
cytoplasm
fine
granular
chromatin
absent
inconspicu
nucleoli
figur
nuclear
mold
characterist
necrosi
common
mitot
rate
typic
high
mean
mitos
per
mm
combin
differ
also
exist
characterist
patient
carcinoid
compar
patient
sclc
lcnec
patient
carcinoid
typic
younger
less
like
smoke
sclc
lcnec
vast
major
current
previou
histori
tobacco
smoke
rare
patient
carcinoid
multipl
endocrin
neoplasia
syndrom
associ
seen
sclc
lcnec
addit
associ
diffus
idiopath
pulmonari
neuroendocrin
cell
hyperplasia
dipnech
note
carcinoid
sclc
lcnec
lead
classif
dipnech
preinvas
lesion
recent
version
classif
scheme
dipnech
diffus
prolifer
singl
cell
small
nodul
ne
bodi
linear
prolifer
pulmonari
ne
cell
may
resid
bronchial
andor
bronchiolar
epithelia
figur
may
accompani
extralumin
prolifer
part
iv
molecular
patholog
human
diseas
tumorlet
carcinoid
howev
morpholog
identifi
precursor
lesion
sclc
lcnec
establish
molecular
marker
pulmonari
ne
tumor
includ
chromogranin
synaptophysin
figur
ncam
marker
express
categori
ne
tumor
higher
frequenc
observ
carcinoid
atyp
carcinoid
small
cell
larg
cell
neuroendocrin
carcinoma
gastrinreleas
peptid
calcitonin
peptid
hormon
insulinomaassoci
promotor
human
achaetescut
gene
also
report
overexpress
tumor
thyroid
transcript
express
sclc
lcnec
carcinoid
sclc
sclc
sqcc
demonstr
larg
often
discontinu
segment
allel
loss
chromosom
area
encompass
multipl
candid
tumor
suppressor
gene
includ
list
previous
atyp
carcinoid
show
higher
frequenc
loh
typic
carcinoid
high
highgrad
ne
tumor
typic
atyp
carcinoid
possess
mutat
multipl
endocrin
neoplasia
gene
chromosom
loh
locu
abnorm
occur
lower
frequenc
sclc
lcnec
support
separ
pathway
tumorigenesi
encod
nuclear
protein
menin
believ
play
sever
role
tumorigenesi
link
transcript
factor
function
histonemodif
pathway
part
interact
famili
transcript
factor
jund
modifi
oncoprotein
tumor
suppressor
protein
oncogen
frequent
amplifi
sclc
includ
myc
mycn
addit
amplifi
gene
repres
candid
oncogen
includ
antiapoptot
gene
myc
protein
transcript
factor
import
cell
cycl
regul
prolifer
dna
synthesi
induc
arf
lead
apoptosi
cellular
condit
favor
prolifer
tsg
inactiv
major
sclc
eighti
percent
sclc
demonstr
mutat
compar
nsclc
fewer
atyp
carcinoid
virtual
typic
carcinoid
mutat
sclc
missens
point
mutat
result
stabil
mutant
protein
easili
detect
immunohistochemistri
protein
overexpress
occur
frequent
highgrad
ne
carcinoma
unusu
typic
carcinoid
intermedi
atyp
carcinoid
dysregul
produc
downstream
effect
bax
antiapoptot
predomin
proapoptot
bax
highgrad
ne
carcinoma
revers
true
carcinoid
lcnec
resembl
sclc
high
rate
mutat
predomin
express
bax
express
alter
compromis
cyclin
pathway
arrest
consist
highgrad
pulmonari
ne
carcinoma
primarili
loss
rb
protein
less
frequent
atyp
carcinoid
uncommon
typic
carcinoid
mutat
gene
exist
mani
sclc
associ
loss
function
gene
product
anoth
studi
ne
carcinoma
exclud
carcinoid
versu
nonn
carcinoma
exhibit
loh
loss
rbprotein
express
hypophosphoryl
form
rb
protein
function
cell
cycl
regul
arrest
cyclin
overexpress
loss
produc
persist
hyperphosphoryl
rb
consequ
evas
cell
cycl
arrest
recent
data
also
suggest
sclc
overexpress
transcript
target
arf
loss
lead
evas
cell
cycl
arrest
rb
pathway
figur
transcript
factor
appear
play
role
cellular
prolifer
activ
gene
requir
phase
entri
product
overexpress
sclc
lcnec
significantli
associ
high
index
bax
ratio
mediat
proteasom
degrad
phase
kinaseassoci
protein
fbox
protein
accumul
highgrad
ne
carcinoma
overexpress
associ
advanc
stage
nodal
metastasi
pulmonari
ne
tumor
highgrad
ne
tumor
appear
interact
stimul
transcript
activ
toward
cyclin
e
promot
telomer
play
import
role
protect
chromosom
degrad
telomeras
enzym
synthes
telomer
dna
strand
serv
counterbal
loss
dna
cell
divis
high
telomeras
activ
note
sclc
lcnec
versu
fewer
typic
carcinoid
express
human
telomeras
mrna
compon
hterc
human
telomeras
revers
transcriptas
htert
mrna
report
respect
typic
carcinoid
atyp
carcinoid
lcnec
sclc
telomer
length
alter
lcnec
sclc
greater
typic
carcinoid
aberr
methyl
cytosineguanin
cpg
island
promot
region
malign
cell
import
mechan
silenc
tsg
epigenet
inactiv
methyl
dna
involv
transfer
methyl
group
dna
methyltransferas
cytosin
cpg
dinucleotid
potenti
tsg
undergo
epigenet
inactiv
virtual
sclc
major
nsclc
hypermethyl
promot
region
ne
tumor
lower
frequenc
methyl
apc
hcadherin
nsclc
sclc
higher
frequenc
methyl
ecadherin
rarb
carcinoid
promot
methyl
encod
apoptosisinduc
cystein
proteas
caspas
also
found
sclc
carcinoid
nsclc
suggest
may
function
tsg
ne
lung
tumor
although
histolog
defin
precursor
sclc
lack
higher
incid
genet
abnorm
found
normal
hyperplas
airway
epithelium
patient
sclc
nsclc
extens
suggest
sclc
may
aris
directli
histolog
normal
mildli
abnorm
epithelium
rather
evolv
sequenc
recogniz
histolog
intermediari
chang
rel
littl
known
molecular
abnorm
precursor
carcinoid
although
carcinoid
view
aris
tumorlet
allel
imbal
significantli
common
carcinoid
tumorlet
may
repres
earli
event
carcinoid
tumor
format
gene
lie
close
proxim
tumor
suppressor
gene
frequent
mutat
ne
tumor
molecular
patholog
dipnech
remain
elucid
mesenchym
neoplasm
includ
classif
scheme
tabl
encompass
spectrum
malign
benign
prolifer
show
differenti
along
multipl
lineag
overal
tumor
much
less
common
lung
epitheli
neoplasm
inform
molecular
pathogenesi
emerg
mesenchym
neoplasm
pulmonari
inflammatori
myofibroblast
tumor
imt
lesion
compos
myofibroblast
cell
collagen
inflammatori
cell
primarili
occur
individu
less
year
age
common
endobronchi
mesenchym
lesion
childhood
figur
synovi
sarcoma
usual
soft
tissu
malign
uncommonli
aris
pleura
lung
often
take
aggress
cours
pulmonari
hamartoma
benign
neoplasm
consist
mixtur
cartilag
fat
connect
tissu
smooth
muscl
present
coin
lesion
chest
radiograph
excis
order
rule
malign
figur
mani
imt
demonstr
clonal
abnorm
rearrang
chromosom
anaplast
lymphoma
kinas
alk
gene
rearrang
involv
fusion
tropomyosin
tpm
ntermin
coiledcoil
domain
alk
ctermin
kinas
domain
produc
two
alk
fusion
gene
encod
oncoprotein
constitut
kinas
activ
like
soft
tissu
counterpart
pulmonari
pleural
synovi
sarcoma
demonstr
chromosom
transloc
x
sytssx
detect
transloc
help
confirm
diagnosi
synovi
sarcoma
unusu
locat
pulmonari
hamartoma
show
abnorm
chromosom
band
region
correspond
mutat
highmobl
group
hmg
protein
famili
nonhiston
chromatinassoci
protein
serv
import
role
regul
chromatin
architectur
gene
express
malign
mesothelioma
mm
uncommon
aggress
tumor
aris
mesotheli
cell
seros
surfac
primarili
pleura
peritoneum
less
often
pericardium
tunica
vaginali
import
risk
factor
mm
exposur
subset
asbesto
fiber
known
amphibol
crocidolit
amosit
incid
tumor
unit
state
peak
earli
appear
declin
like
relat
decreas
use
amphibol
sinc
peak
period
import
tumor
character
long
latenc
period
asbesto
exposur
clinic
present
tumor
mean
year
radiat
nonasbesto
fiber
known
erionit
potenti
process
associ
pleural
scar
also
implic
causat
smaller
number
case
malign
mesothelioma
role
simian
viru
genesi
tumor
suggest
remain
controversi
pleural
mm
commonli
aris
male
age
present
featur
typic
includ
hemorrhag
pleural
effus
associ
short
breath
chest
wall
pain
weight
loss
malais
common
time
tumor
discov
patient
usual
extens
involv
pleural
surfac
progress
tumor
typic
invad
lung
chest
wall
diaphragm
lymph
node
metastasi
caus
superior
vena
caval
obstruct
cardiac
tamponad
subcutan
nodul
contralater
lung
involv
also
occur
time
diagnosi
median
surviv
month
treatment
may
includ
surgeri
chemotherapi
radiotherapi
immunotherapi
treatment
often
combin
intent
surgeri
usual
palli
whether
extrapleur
pneumonectomi
chemotherapi
radiotherapi
lead
cure
unclear
new
agent
current
investig
potenti
improv
life
expect
qualiti
life
patient
aggress
malign
gross
patholog
featur
mm
includ
pleural
nodul
grow
coalesc
fill
pleural
caviti
form
thick
rind
around
lung
firm
tan
appear
common
occasion
tumor
gelatin
consist
figur
extens
along
interlobar
fissur
invas
adjac
lung
diaphragm
chest
wall
characterist
spread
occur
pericardi
caviti
around
mediastin
structur
distant
metastas
also
develop
histolog
mm
manifest
wide
varieti
histolog
pattern
major
histolog
categori
includ
epithelioid
mesothelioma
sarcomatoid
mesothelioma
desmoplast
mesothelioma
biphas
mesothelioma
epithelioid
mesothelioma
consist
round
ovoid
polygon
cell
eosinophil
cytoplasm
nuclei
usual
round
littl
cytoatypia
figur
cell
often
form
sheet
tubulopapillari
structur
glandlik
arrang
tumor
myxoid
appear
due
product
larg
amount
hyaluron
sarcomatoid
mesothelioma
compos
malignantappear
spindl
cell
occasion
accompani
matur
sarcomat
compon
osteosarcoma
chondrosarcoma
other
desmoplast
mesothelioma
diagnost
challeng
due
frequent
bland
appear
resembl
organ
pleuriti
consist
variabl
atyp
spindl
cell
dens
collagen
matrix
figur
help
featur
separ
figur
malign
mesothelioma
tanwhit
tumor
involv
entir
pleura
surround
compress
underli
parenchyma
appear
congest
rel
unremark
chapter
molecular
basi
pulmonari
diseas
tumor
organ
pleuriti
includ
invas
chest
wall
muscl
adipos
tissu
necrosi
biphas
mesothelioma
includ
epithelioid
sarcomatoid
element
compris
least
tumor
patholog
diagnosi
mm
greatli
assist
expand
avail
antibodi
use
immunohistochemistri
mesotheli
differenti
support
immunoreact
cytokeratin
calretinin
figur
antibodi
histolog
distinct
epithelioid
mesothelioma
metastat
ac
common
need
practic
panel
approach
use
calretinin
cytokeratin
antibodi
reactiv
ac
cea
leu
other
usual
success
electron
microscopi
also
help
difficult
case
demonstr
long
thin
microvilli
mani
mm
epithelioid
compon
pancytokeratin
stain
help
support
diagnosi
sarcomatoid
desmoplast
mm
oppos
sarcoma
sinc
sarcoma
stain
pancytokeratin
mesotheli
mesenchym
marker
also
use
assist
differenti
mm
histolog
similar
sarcoma
precursor
lesion
mm
clearli
defin
histolog
standpoint
although
like
situ
stage
exist
term
atyp
mesotheli
hyperplasia
recommend
surfac
noninvas
prolifer
mesotheli
cell
uncertain
malign
potenti
exposur
asbesto
fiber
believ
trigger
pathobiolog
chang
lead
major
mm
current
believ
asbesto
may
act
initi
genet
promot
epigenet
develop
mm
degre
tumorigenesi
result
direct
interact
fiber
mesotheli
cell
mechan
involv
oxid
stress
unresolv
multipl
chromosom
alter
often
note
mm
inactiv
tsg
play
import
part
pathogenesi
mm
varieti
genet
abnorm
report
includ
delet
proxim
monosomi
gain
part
iv
molecular
patholog
human
diseas
common
genet
abnorm
mm
delet
encompass
locu
encod
tumor
suppressor
arf
particip
rb
pathway
inhibit
cell
cycl
progress
figur
recent
studi
shown
larg
antigen
present
mm
inactiv
tsg
product
rb
rais
possibl
asbesto
could
act
cocarcinogen
mm
suggest
perturb
rband
growthregulatori
pathway
may
involv
pathogenesi
mm
common
find
includ
inactiv
mutat
allel
loss
tsg
neurofibromin
found
chromosom
inactiv
arf
anoth
tsg
promot
methyl
loss
arf
also
result
inactiv
howev
mm
unlik
mani
epitheli
tumor
mutat
rb
ra
gene
rare
wnt
signal
transduct
pathway
also
abnorm
activ
mm
appear
play
role
pathogenesi
activ
pathway
lead
accumul
bcatenin
cytoplasm
transloc
nucleu
interact
tcf
lef
transcript
factor
promot
express
multipl
gene
includ
cmyc
cyclin
mechan
activ
appear
involv
mutat
bcatenin
gene
may
instead
involv
upstream
compon
pathway
dishevel
protein
recent
evid
also
suggest
phosphatidylinositol
pathway
frequent
activ
mm
inhibit
pathway
increas
sensit
chemotherapeut
agent
wilm
tumor
gene
also
express
mm
role
pathogenesi
mm
unclear
final
egfr
signal
mm
recent
becom
focu
greater
attent
data
show
egfr
earli
cell
membran
target
asbesto
fiber
link
activ
mapk
cascad
unfortun
phase
ii
clinic
trial
gefitinib
treatment
patient
mm
show
effect
despit
egfr
overexpress
case
anoth
studi
found
common
egfr
mutat
confer
sensit
gefitinib
preval
human
malign
mesothelioma
investig
continu
new
potenti
efficaci
agent
treatment
mm
nonneoplast
pulmonari
patholog
compris
inflammatori
fibros
diseas
conduct
airway
alveoli
vessel
lymphoid
tissu
patholog
may
local
diffus
may
either
obviou
etiolog
idiopath
may
caus
injuri
repar
irrepar
importantli
understand
nonneoplast
lung
patholog
play
vital
role
clinic
manag
diseas
section
cover
major
type
obstruct
interstiti
diseas
vascular
lesion
pneumonia
occup
diseas
major
histiocyt
condit
common
development
anomali
list
includ
nonneoplast
diseas
affect
lung
repres
respons
major
ill
also
condit
highlight
within
categori
best
understand
molecular
biolog
diseas
mechan
obstruct
lung
diseas
character
reduct
airflow
due
airway
narrow
airflow
reduct
occur
gener
two
basic
mechan
inflamm
injuri
airway
result
obstruct
mucou
cellular
debri
within
around
airway
lumen
ii
destruct
elastin
fiber
alveolar
wall
caus
loss
elast
recoil
subsequ
prematur
collaps
airway
expiratori
phase
respir
four
major
obstruct
lung
diseas
asthma
emphysema
chronic
bronchiti
bronchiectasi
asthma
chronic
inflammatori
diseas
airway
affect
million
peopl
worldwid
preval
disabl
asthma
increas
sinc
rang
low
rural
ethiopia
among
children
part
central
south
america
unit
state
asthma
affect
approxim
popul
lead
caus
hospit
among
children
less
year
age
clinic
diseas
defin
gener
obstruct
airflow
revers
occur
spontan
therapi
character
recurr
wheez
cough
short
breath
result
airway
hyperact
mucu
hypersecret
hyperrespons
result
acut
bronchospasm
elicit
diagnost
purpos
use
histamin
methacholin
challeng
key
featur
symptom
variablewors
night
earli
morn
peopl
wors
exercis
previous
assum
symptom
separ
interv
normal
physiolog
howev
evid
accumul
asthma
caus
progress
lung
impair
due
chronic
morpholog
chang
airway
treatment
strategi
complex
diseas
myriad
atop
individu
allergen
avoid
primari
therapi
exampl
children
reduc
exposur
hous
dust
mite
earli
life
decreas
sensit
incid
diseas
develop
diseas
avoid
allergen
later
life
improv
symptom
control
establish
treatment
asthma
flair
includ
inhal
corticosteroid
shortact
longact
agonist
phosphodiesteras
pde
inhibitor
theophyllin
use
decad
treat
asthmat
bronchoconstrict
cardiac
central
nervou
system
side
effect
limit
use
newer
pde
inhibitor
without
side
effect
includ
nonxanthin
drug
rofumilast
patholog
chang
airway
asthma
similar
seen
chronic
bronchiti
consist
thicken
basement
membran
epitheli
desquam
goblet
cell
hyperplasia
subepitheli
elastin
deposit
wall
airway
smooth
muscl
hypertrophi
submucos
gland
hyperplasia
also
present
figur
acut
asthma
exacerb
transmur
chronic
inflammatori
infiltr
variabl
amount
eosinophilia
may
present
result
epitheli
injuri
desquam
becom
quit
pronounc
one
see
clump
degener
epitheli
cell
mix
mucin
lumen
airway
aggreg
degener
cell
refer
creola
bodi
seen
expector
mucin
patient
also
present
sputum
sampl
charcotleyden
crystal
rhomboidshap
structur
repres
breakdown
product
eosinophil
cytoplasm
granul
figur
chang
seen
wall
airway
repres
longterm
airway
remodel
caus
prolong
inflamm
remodel
may
play
role
pathophysiolog
asthma
amount
airway
remodel
highli
variabl
patient
patient
remodel
found
even
patient
mild
asthma
current
effect
treatment
chronic
patholog
unclear
pathogenesi
asthma
complex
like
involv
genet
environment
compon
expert
see
diseas
insult
initi
seri
event
genet
suscept
host
singl
gene
account
famili
compon
diseas
genet
analysi
patient
reveal
preval
specif
hla
allel
polymorph
fc
erib
asthma
classifi
use
number
differ
schema
commonli
asthma
divid
two
categori
atop
allerg
nonatop
nonallerg
atop
asthma
result
allerg
sensit
usual
earli
life
onset
earli
childhood
nonatop
asthma
lateonset
though
immunopatholog
well
studi
probabl
similar
mechan
atop
asthma
although
nosolog
conveni
purpos
understand
mechan
diseas
patient
manifest
combin
two
categori
overlap
symptom
pathogenet
mechan
type
encompass
varieti
cell
product
includ
airway
epithelium
smooth
muscl
cell
fibroblast
mast
cell
eosinophil
tcell
asthma
respons
includ
two
phase
earli
respons
compris
acut
bronchospast
event
within
minut
exposur
late
respons
peak
approxim
hour
prolong
effect
one
want
understand
complex
respons
best
divid
three
compon
type
hypersensit
respons
ii
acut
chronic
inflamm
iii
bronchial
hyperact
type
hypersensit
gener
human
asthma
associ
predomin
type
helper
cell
phenotyp
cell
result
uptak
process
viral
allergen
environment
trigger
initi
episod
process
includ
present
trigger
airway
dendrit
cell
naiv
tcell
result
differenti
popul
differenti
result
releas
dendrit
cell
cell
part
iv
molecular
patholog
human
diseas
propag
inflammatori
reaction
two
way
first
releas
varieti
cytokin
mediat
wide
varieti
respons
stimul
bcell
plasma
cell
produc
ige
turn
stimul
mast
cell
matur
releas
multipl
mediat
includ
histamin
leukotrien
second
cell
secret
togeth
also
stimul
mast
cell
secret
histamin
tryptas
chymas
cysteinyl
leukotrien
caus
bronchoconstrictor
respons
occur
rapidli
exposur
allergen
lymphocyt
also
recruit
eosinophil
airway
stimul
releas
content
granul
includ
eosinophil
cation
protein
ecp
major
basic
protein
mbp
eosinophil
peroxidas
eosinophilderiv
neurotoxin
compound
induc
bronchial
wall
hyperact
also
respons
increas
vascular
permeabl
produc
transmur
edema
airway
cell
differenti
cell
result
produc
dendrit
cell
cell
produc
interferongamma
ifng
lymphotoxin
play
role
macrophag
activ
delayedtyp
hypersensit
reaction
seen
diseas
rheumatoid
arthriti
tuberculosi
cell
predominantli
respons
defens
intracellular
organ
promin
normal
airway
airway
patient
emphysema
asthmat
howev
sever
form
asthma
cell
recruit
capac
secret
tumor
necrosi
factor
tnf
ifng
may
lead
tissuedamag
immun
respons
one
see
airway
figur
acut
chronic
inflamm
role
acut
chronic
inflammatori
cell
includ
eosinophil
mast
cell
macrophag
lymphocyt
asthma
evid
abund
cell
airway
sputum
bronchoalveolar
sampl
patient
diseas
number
eosinophil
airway
correl
sever
asthma
amount
bronchial
hyperrespons
protein
releas
cell
includ
ecp
mcp
eosinophilderiv
neurotoxin
caus
least
epitheli
damag
seen
activ
form
asthma
neutrophil
promin
acut
exacerb
asthma
probabl
recruit
airway
potent
neutrophil
chemoattract
releas
airway
epitheli
cell
cell
also
releas
proteas
reactiv
oxygen
speci
ro
proinflammatori
mediat
addit
epitheli
damag
also
contribut
airway
destruct
remodel
occur
chronic
form
diseas
suscept
epithelium
asthma
oxid
injuri
may
increas
due
decreas
antioxid
superoxid
dismutas
lung
final
mast
cell
activ
releas
abund
mediat
bind
ige
fceri
highaffin
receptor
surfac
allergen
bind
ige
molecul
induc
crosslink
molecul
lead
activ
mast
cell
releas
number
mediat
notabl
histamin
tryptas
variou
leukotrien
includ
leukotrien
ltd
interact
smooth
muscl
induc
contract
acut
bronchospast
respons
allergen
bronchial
hyperact
cornerston
asthma
hyperact
respons
airway
smooth
muscl
mechan
occur
combin
neural
pathway
inflammatori
pathway
state
inflammatori
compon
respons
come
predominantli
mast
cell
major
neural
pathway
involv
nonadrenerg
noncholinerg
nanc
system
although
cholinerg
pathway
respons
maintain
airway
smooth
muscl
tone
nanc
system
releas
bronchoact
tachykinin
substanc
p
neurokinin
bind
receptor
smooth
muscl
caus
constrict
character
acut
asthmat
respons
addit
acut
mechan
airway
also
undergo
structur
alter
form
element
mucosa
chang
includ
goblet
cell
hyperplasia
basement
membran
thicken
within
submucosa
airway
wall
increas
deposit
collagen
elast
fiber
result
fibrosi
elastosi
smooth
muscl
cell
submucos
gland
undergo
hypertrophi
hyperplasia
irrevers
chang
consequ
chronic
inflammatori
insult
airway
mechan
includ
releas
fibros
mediat
tgfb
mitogen
mediat
epiderm
fibroblast
growth
factor
egf
fgf
exact
mechan
occur
clearli
defin
similar
factor
involv
branch
morphogenesi
develop
lung
led
focu
effect
inflamm
interact
epithelium
underli
mesenchym
cell
term
chronic
obstruct
pulmonari
diseas
copd
appli
emphysema
chronic
bronchiti
bronchiectasi
diseas
airflow
limit
usual
progress
unlik
asthma
fulli
revers
preval
copd
worldwid
estim
adult
age
though
differ
form
copd
differ
etiolog
clinic
manifest
common
form
diseas
includ
progress
declin
lung
function
usual
measur
decreas
forc
expiratori
flow
second
chronic
cough
dyspnea
emphysema
chronic
bronchiti
common
diseas
copd
result
cigarett
smoke
usual
exist
togeth
smoker
chronic
bronchiti
defin
clinic
persist
cough
sputum
product
least
month
least
consecut
year
without
identifi
caus
patient
chronic
bronchiti
typic
copiou
sputum
promin
cough
commonli
get
infect
typic
experi
hypercapnia
sever
hypoxemia
give
rise
clinic
monik
blue
bloater
emphysema
destruct
perman
enlarg
air
space
distal
termin
bronchiol
without
obviou
fibrosi
patient
slight
cough
overinfl
lung
sever
inspir
term
pink
puffer
patholog
featur
copd
best
understood
one
consid
whole
copd
spectrum
patholog
consist
emphysemat
tissu
destruct
airway
inflamm
remodel
obstruct
lung
patient
copd
usual
contain
featur
vari
proport
patholog
featur
chronic
bronchiti
includ
mucos
patholog
consist
epitheli
inflamm
injuri
regen
epitheli
chang
squamou
goblet
cell
metaplasia
addit
submucosa
show
chang
remodel
smooth
muscl
hypertrophi
submucos
gland
hyperplasia
chang
respons
copiou
secret
characterist
clinic
diseas
although
studi
report
consist
relationship
patholog
featur
larg
airway
airflow
obstruct
patholog
definit
emphysema
abnorm
perman
enlarg
airspac
distal
termin
bronchiol
accompani
destruct
alveolar
wall
without
fibrosi
four
major
patholog
pattern
emphysema
defin
locat
destruct
includ
centriacinar
panacinar
parasept
irregular
emphysema
first
two
respons
overwhelm
major
clinic
diseas
centriacinar
emphysema
sometim
refer
centrilobular
repres
case
result
destruct
alveoli
proxim
central
area
pulmonari
acinu
includ
respiratori
bronchiol
figur
predominantli
affect
upper
lobe
remain
two
type
emphysema
parasept
irregular
rare
associ
clinic
diseas
parasept
emphysema
damag
distal
acinu
area
abut
pleura
margin
lobul
damag
area
may
caus
spontan
pneumothorac
typic
young
thin
men
irregular
emphysema
tissu
destruct
alveolar
enlarg
occur
adjac
scar
secondari
enhanc
inflamm
area
though
common
find
scar
lung
littl
clinic
signific
patient
though
emphysema
lung
play
domin
role
caus
obstruct
small
airway
patholog
also
present
respiratori
bronchiol
refer
inflammatori
chang
found
distal
airway
smoker
consist
pigment
macrophag
fill
lumen
peribronchiolar
airspac
mild
chronic
inflamm
fibrosi
around
bronchiol
figur
pigment
macrophag
repres
inhal
particul
matter
cigarett
smoke
phagocyt
cell
macrophag
turn
releas
proteas
destroy
elast
fiber
surround
area
result
loss
elast
recoil
obstruct
symptom
gener
copd
result
inflamm
larg
airway
produc
airway
remodel
characterist
chronic
bronchiti
well
inflamm
smaller
airway
result
destruct
adjac
tissu
consequ
emphysema
predomin
inflammatori
cell
involv
process
alveolar
macrophag
neutrophil
lymphocyt
main
theori
pathogenesi
copd
support
interact
airway
inflamm
two
main
system
lung
proteaseantiproteas
system
oxidantantioxid
system
system
help
protect
lung
mani
irrit
enter
lung
via
larg
pulmonari
surfac
area
interfac
environ
proteaseantiproteas
system
proteas
produc
number
cell
includ
epitheli
cell
inflammatori
cell
degrad
underli
lung
matrix
import
proteas
lung
neutrophil
elastas
part
serin
proteas
famili
metalloproteinas
mmp
produc
predominantli
macrophag
proteas
secret
respons
invas
environment
irrit
notabl
infecti
agent
bacteria
set
role
enzymat
degrad
organ
howev
proteas
also
secret
inflammatori
epitheli
cell
normal
lung
repair
maintain
underli
lung
matrix
protein
protect
lung
unwant
destruct
enzym
liver
secret
antiproteas
circul
bloodstream
lung
inhibit
action
proteas
addit
macrophag
secret
mmp
also
secret
tissu
inhibitor
metalloproteinas
timp
delic
balanc
proteas
antiproteas
need
maintain
integr
lung
structur
imbal
result
rel
excess
proteas
either
overproduct
proteas
underproduct
inhibitor
lead
tissu
destruct
format
emphysema
imbal
occur
differ
way
two
major
type
emphysema
centriacinar
panacinar
centriacinar
emphysema
caus
primarili
cigarett
smoke
overproduct
proteas
primarili
due
stimulatori
effect
chemic
within
smoke
neutrophil
macrophag
though
exact
mechan
complet
understood
studi
support
nicotin
cigarett
smoke
act
chemoattract
ro
also
contain
smoke
stimul
increas
releas
neutrophil
elastas
mmp
activ
macrophag
lead
destruct
elastin
alveolar
space
inflammatori
cell
activ
may
come
activ
transcript
factor
nfkb
lead
tnfa
product
addit
elastin
peptid
may
attract
addit
inflammatori
cell
increas
proteas
secret
exacerb
matrix
destruct
unlik
centriacinar
emphysema
panacinar
emphysema
commonli
caus
genet
defici
antiproteas
usual
due
antitrypsin
aat
defici
condit
affect
approxim
peopl
unit
state
aat
defici
due
defect
gene
encod
protein
aat
glycoprotein
produc
hepatocyt
main
inhibitor
neutrophil
elastas
affect
gene
gene
formerli
known
locat
long
arm
chromosom
genet
mutat
occur
categor
four
group
base
substitut
infram
delet
frameshift
mutat
exon
delet
mutat
usual
result
misfold
polymer
retent
aberr
protein
within
hepatocyt
lead
decreas
circul
level
aat
defici
autosom
codomin
diseas
allel
variant
allel
common
allel
produc
normal
serum
level
lessact
protein
individu
manifest
lung
diseas
usual
homozyg
allel
z
zz
ss
phenotyp
heterozyg
allel
mz
sz
phenotyp
aat
concentr
plasma
less
normal
confer
risk
emphysema
individu
zz
genotyp
activ
aat
approxim
onefifth
normal
second
system
lung
involv
pathogenesi
emphysema
oxidantantioxid
system
proteas
system
lung
protect
oxid
stress
form
ro
antioxid
produc
cell
lung
ro
lung
includ
oxygen
ion
free
radic
peroxid
major
antioxid
airway
enzym
includ
catalas
superoxid
dismutas
sod
glutathion
peroxidas
glutathion
stransferas
xanthin
oxidas
thioredoxin
well
nonenzymat
antioxid
includ
glutathion
ascorb
urat
bilirubin
balanc
oxid
antioxid
lung
prevent
damag
ro
howev
cigarett
smoke
increas
product
ro
neutrophil
eosinophil
macrophag
epitheli
cell
evid
damag
lung
epithelium
matrix
direct
result
ro
includ
presenc
exhal
h
decreas
plasma
antioxid
increas
plasma
tissu
level
oxid
protein
includ
variou
lipid
peroxid
product
addit
direct
effect
ro
may
also
induc
proinflammatori
respons
recruit
inflammatori
cell
lung
anim
model
cigarett
smoke
induc
express
proinflammatori
cytokin
tnfa
macrophag
epitheli
cell
fibroblast
perhap
activ
transcript
factor
nfkb
figur
final
evid
cigarett
smoke
disturb
oxidantantioxid
balanc
lung
deplet
antioxid
ascorb
glutathion
bronchiectasi
repres
perman
remodel
dilat
larg
airway
lung
commonli
due
chronic
inflamm
recurr
pneumonia
infect
usual
occur
airway
secret
entrap
organ
effect
clear
patholog
dictat
clinic
featur
diseas
includ
chronic
cough
copiou
secret
histori
recurr
pneumonia
five
major
caus
bronchiectasi
infect
obstruct
impair
mucociliari
defens
impair
system
immun
defens
congenit
may
produc
either
local
diffus
form
diseas
local
bronchiectasi
usual
due
obstruct
airway
mass
lesion
scar
previou
injuri
infect
diffus
bronchiectasi
result
defect
system
immun
defens
either
innat
adapt
immun
may
impair
diseas
due
former
includ
chronic
granulomat
diseas
cgd
diseas
due
latter
includ
agammaglobulinemiahypogammaglobulinemia
sever
combin
immun
defici
defect
mucociliari
defens
mechan
respons
physic
clear
organ
lung
may
also
caus
diffus
bronchiectasi
includ
ciliari
dyskinesia
result
cilia
aberr
ultrastructur
cystic
fibrosi
cf
congenit
form
bronchiectasi
rare
exist
common
includ
mounierkuhn
syndrom
williamscampbel
syndrom
former
caus
enlarg
trachea
major
bronchi
due
loss
bronchial
cartilag
latter
caus
diffus
bronchiectasi
major
airway
probabl
due
genet
defect
connect
tissu
patholog
bronchiectasi
dramat
seen
gross
level
one
see
dilat
airway
contain
copiou
amount
infect
secret
mucou
plug
local
either
segment
lung
diffus
involv
entir
lung
cystic
fibrosi
figur
microscop
featur
includ
chronic
inflammatori
chang
similar
chronic
bronchiti
ulcer
mucosa
submucosa
lead
destruct
smooth
muscl
elast
airway
wall
characterist
dilat
fibrosi
enlarg
airway
contain
mucou
plug
compris
mucin
abund
degener
inflammatori
cell
result
infect
establish
airway
follow
loss
mucociliari
defens
mechan
bacteria
may
found
plug
notabl
p
aeruginosa
pathogenet
mechan
bronchiectasi
complex
depend
underli
etiolog
gener
initi
damag
bronchial
epithelium
due
aberr
mucin
cystic
fibrosi
dysfunct
cilia
ciliari
dyskinesia
ineffect
immun
surveil
defect
innat
antibodymedi
immun
lead
cycl
tissu
injuri
repair
remodel
ultim
destroy
normal
airway
initi
event
cycl
usual
involv
dysfunct
mucociliari
mechan
inhibit
expuls
lung
organ
foreign
substanc
invad
airway
may
due
defect
cilia
mucin
ciliari
defect
found
primari
ciliari
dyskinesia
genet
heterogen
disord
usual
inherit
autosom
recess
trait
produc
immotil
cilia
clinic
manifest
lung
sinus
middl
ear
male
fertil
organ
later
protein
make
axonem
cilia
mutat
gene
encod
protein
outer
dynein
arm
frequent
caus
disord
cf
main
defect
affect
mucin
patient
autosom
recess
condit
low
volum
airway
surfac
liquid
asl
caus
sticki
mucin
inhibit
normal
ciliari
motion
effect
mucociliari
clearanc
organ
due
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
locat
chromosom
encod
campactiv
channel
regul
flow
chlorid
ion
cell
intracellular
vacuol
help
maintain
osmol
mucin
protein
present
predominantli
apic
membran
airway
epitheli
cell
though
also
involv
consider
subap
intracellular
traffick
recycl
cours
matur
within
cell
genet
diseas
manifest
multipl
organ
depend
chlorid
ion
transport
maintain
normal
secret
includ
pancrea
intestin
liver
reproduct
organ
sweat
gland
genet
mutat
cf
influenc
cftr
traffick
distal
compart
protein
secretari
pathway
variou
genet
mutat
produc
differ
clinic
phenotyp
diseas
mutat
cftr
gene
found
howev
four
mutat
occur
frequenc
greater
mutat
group
five
class
accord
function
deficit
group
cftr
synthes
group
ii
cftr
inadequ
process
group
iii
cftr
regul
group
iv
cftr
show
abnorm
conduct
group
v
cftr
partial
defect
product
process
approxim
cf
patient
group
ii
mutat
cftr
delet
phenylalanin
codon
patient
cftr
protein
misfold
undergo
prematur
degrad
within
endoplasm
reticulum
though
small
amount
cftr
protein
present
apic
membran
function
normal
cf
patient
may
combin
genet
mutat
five
group
howev
patient
sever
diseas
involv
lung
pancrea
usual
carri
least
two
mutat
group
ii
iii
system
immun
defici
caus
bronchiectasi
establish
persist
infect
inflamm
four
major
categori
immun
defici
first
categori
consist
number
genet
diseas
caus
either
agammaglobulinemia
hypogammaglobulinemia
includ
xlink
agammaglobulinemia
xla
common
variabl
immunodefici
cvi
xla
caus
mutat
bruton
tyrosin
kinas
btk
gene
result
virtual
absenc
immunoglobulin
isotyp
circul
b
lymphocyt
cvi
mark
reduct
igg
iga
andor
igm
associ
defect
antibodi
respons
protein
polysaccharid
antigen
expect
diseas
increas
suscept
infect
encapsul
bacteria
second
categori
immun
defici
hyperig
syndrom
diseas
markedli
elev
serum
ige
level
character
recurr
staphylococc
infect
third
categori
chronic
granulomat
diseas
cgd
genet
heterogen
group
disord
defect
phagocyt
respiratori
burst
superoxid
product
inhibit
abil
kill
staphylococcu
spp
fungi
aspergillu
spp
final
sever
combin
immun
defici
scid
compris
group
disord
abnorm
tcell
develop
bcell
andor
natur
killer
cell
matur
function
predispos
patient
pneumocysti
jiroveci
viral
infect
initi
insult
subsequ
step
develop
bronchiectasi
includ
destruct
epitheli
cell
bronchial
wall
connect
tissu
matrix
proteas
ro
secret
neutrophil
proinflammatori
milieu
produc
multipl
factor
first
infect
persist
lung
due
defect
host
immun
system
mechan
certain
organ
develop
evad
immun
defens
exampl
pseudomona
aeruginosa
chang
nonmucoid
mucoid
variant
also
releas
virul
factor
protect
phagocytosi
second
case
cystic
fibrosi
neutrophil
directli
recruit
proinflammatori
cytokin
releas
bronchial
epitheli
cell
result
defect
cgft
protein
final
necrot
cellular
debri
breakdown
product
act
chemoattract
recruit
inflammatori
cell
airway
wall
exacerb
damag
final
phase
repair
remodel
begin
macrophag
invad
recruit
fibroblast
secret
collagen
lead
fibrosi
seen
patholog
howev
absenc
effect
airway
clearanc
mechan
ectat
airway
remain
reservoir
infect
continu
cycl
inflamm
tissu
destruct
idiopath
interstiti
pneumonia
iip
compris
group
diffus
infiltr
pulmonari
diseas
similar
clinic
present
character
dyspnea
restrict
physiolog
bilater
interstiti
infiltr
chest
radiographi
patholog
diseas
characterist
pattern
tissu
injuri
chronic
inflamm
vari
amount
fibrosi
recogn
pattern
pathologist
classifi
entiti
predict
prognosi
howev
pathologist
establish
etiolog
sinc
patholog
pattern
seen
multipl
clinic
set
patholog
classif
diseas
origin
defin
liebow
carrington
undergon
import
revis
past
year
latest
revis
american
thorac
societyeuropean
respiratori
societi
best
known
preval
entiti
iip
idiopath
pulmonari
fibrosi
ipf
known
patholog
usual
interstiti
pneumonia
uip
uip
histolog
pattern
character
patchi
area
chronic
lymphocyt
inflamm
organ
collagen
type
fibrosi
patient
usual
present
gradual
increas
short
breath
nonproduct
cough
symptom
mani
month
even
year
imag
studi
usual
reveal
bilater
basilar
diseas
reticular
pattern
therapi
begin
corticosteroid
advanc
cytotox
drug
methotrex
cytoxan
current
therapi
effect
stop
progress
diseas
current
estim
male
femal
diseas
progress
respiratori
failur
death
within
year
patholog
character
lead
edg
chronic
inflamm
fibroblast
foci
begin
differ
area
lung
differ
time
process
produc
varieg
pattern
fibrosi
usual
refer
tempor
heterogen
pattern
injuri
occur
predominantli
peripheri
lung
involv
subpleura
interlobular
septa
gross
pictur
one
advanc
peripher
basilar
diseas
figur
progress
inflamm
fibrosi
includ
interstiti
widen
epitheli
injuri
slough
fibroblast
infiltr
organ
fibrosi
within
characterist
fibroblast
foci
deposit
collagen
fibroblast
occur
latter
stage
repair
presenc
abund
collagen
produc
stiff
lung
unabl
clear
airway
secret
lead
recurr
inflamm
bronchiolar
epithelium
eventu
fibrosi
breakdown
airway
structur
remodel
produc
mucousfil
ectat
space
give
rise
gross
pictur
honeycomb
space
seen
advanc
patholog
figur
theori
pathogenesi
ipf
evolv
past
decad
earli
theori
favor
primari
inflammatori
process
current
theori
favor
concept
fibrosi
lung
proce
independ
inflammatori
event
develop
aberr
epitheli
epithelialmesenchym
respons
injuri
alveolar
epitheli
cell
aec
aec
consist
two
popul
type
pneumocyt
type
pneumocyt
normal
lung
type
pneumocyt
line
alveolar
wall
type
pneumocyt
line
remain
howev
lung
injuri
type
cell
exquisit
fragil
undergo
cell
death
type
pneumocyt
serv
progenitor
cell
regener
alveolar
epithelium
though
studi
suggest
repopul
type
cell
depend
circul
stem
cell
concept
remain
fulli
proven
accord
current
concept
injuri
andor
apoptosi
aec
initi
cascad
cellular
event
produc
scar
lung
studi
aec
lung
patient
ipf
shown
ultrastructur
evid
cell
injuri
apoptosi
well
express
proapoptot
protein
inhibit
apoptosi
block
varieti
proapoptot
mechan
fasfa
ligand
pathway
angiotensin
tnfa
product
caspas
activ
stop
progress
fibrosi
result
aec
injuri
migrat
prolifer
activ
fibroblast
myofibroblast
lead
format
characterist
fibroblast
foci
uip
patholog
deposit
accumul
collagen
elast
fiber
alveoli
figur
uniqu
patholog
may
result
increas
product
profibrot
factor
transform
growth
factora
tgfa
tgfb
fibroblast
growth
insulinlik
growth
plateletderiv
growth
factor
altern
pathway
might
involv
overproduct
inhibitor
matrix
degrad
timp
tissu
inhibitor
matrix
product
support
former
mechan
fibroblast
isol
lung
ipf
patient
exhibit
profibrot
secretori
phenotyp
multipl
factor
environment
particul
drug
chemic
exposur
virus
may
trigger
initi
epitheli
injuri
genet
factor
also
play
role
approxim
patient
ipf
famili
histori
diseas
inherit
pattern
autosom
domin
variabl
penetr
two
genet
mutat
implic
famili
form
ipf
one
larg
kindr
report
mutat
gene
encod
surfact
protein
c
six
proband
b
report
heterozyg
mutat
gene
htert
htr
encod
telomeras
revers
transcriptas
telomeras
rna
respect
result
mutant
telomeras
short
telomer
adult
respiratori
distress
syndrom
ard
repres
constel
clinic
radiolog
physiolog
featur
patient
acut
respiratori
failur
occur
varieti
insult
ard
defin
clinic
criteria
includ
rapid
onset
sever
hypoxemia
refractori
oxygen
therapi
presenc
abnorm
chest
radiograph
evid
bilater
alveolar
fill
collaps
increas
pulmonari
arteri
occlus
pressur
resist
improv
oxygen
regardless
mechan
ventil
therapi
treatment
ard
includ
elimin
underli
caus
protect
ventil
strategi
improv
oxygen
support
treatment
may
includ
administr
corticosteroid
patholog
ard
diffus
alveolar
damag
dad
whose
histolog
pictur
one
inflamm
fibrosi
diffus
involv
structur
alveolu
similar
throughout
affect
area
lung
dad
divid
three
major
phase
follow
chronolog
origin
insult
exud
prolif
fibrot
dad
initi
injuri
primarili
involv
epithelium
alveolar
wall
endothelium
capillari
caus
destruct
slough
type
pneumocyt
alveolar
space
breakdown
tight
junction
endothelium
combin
two
event
result
loss
epithelialendotheli
barrier
alveolu
leakag
plasma
capillari
alveolar
space
flood
airspac
fluid
markedli
decreas
oxygen
exchang
caus
hypoxia
patient
experi
addit
acut
inflammatori
chang
endothelium
also
caus
thrombi
form
vessel
ad
decreas
amount
blood
circul
lung
compromis
ga
exchang
air
brought
alveoli
posit
pressur
within
alveolar
space
forc
plasma
alveolar
wall
produc
membran
morpholog
refer
hyalin
membran
characterist
first
phase
dad
refer
exud
dad
figur
initi
injuri
follow
sequenc
event
repres
lung
effort
repair
first
type
pneumocyt
undergo
hyperplasia
reepitheli
alveolar
wall
loss
type
cell
reestablish
epitheli
barrier
cell
secret
surfact
result
increas
surfact
product
lower
surfac
tension
alveolu
inhibit
collaps
increas
number
type
pneumocyt
known
prolif
phase
dad
figur
final
phase
dad
fibrot
dad
fibroblast
migrat
adjac
interstitium
alveolar
space
produc
organ
irrevers
fibrosi
within
alveolar
space
interstitium
addit
mechan
fibrosi
may
also
occur
area
alveolar
wall
collaps
surfact
decreas
initi
insult
histopatholog
pictur
fibrot
phase
one
thicken
alveolar
septa
intraalveolar
granul
tissu
microcyst
format
area
irregular
alveolar
scar
rare
case
microcyst
progress
larg
cyst
adult
equival
bronchopulmonari
dysplasia
cellular
event
dad
complex
incomplet
understood
gener
diseas
broken
two
phase
first
larg
influx
neutrophil
plasma
enter
alveolar
space
role
neutrophil
play
initi
cellular
injuri
death
unclear
known
necessari
injuri
occur
addit
clinic
studi
shown
within
peripher
blood
bronchoalveolar
lavag
bal
patient
neutrophil
present
along
myriad
proinflammatori
cytokin
tgfa
capabl
recruit
lung
also
present
fluid
mediat
recruit
fibroblast
tgfb
mediat
probabl
result
upregul
nfkb
proinflammatori
transcript
factor
alveolar
macrophag
adher
neutrophil
capillari
endothelium
lung
occur
adhes
molecul
selectin
integrin
immunoglobulin
neutrophil
adher
subsequ
transmigr
endothelium
lung
capillari
may
caus
endotheli
damag
howev
specul
ro
reactiv
nitrogen
chapter
molecular
basi
pulmonari
diseas
speci
rn
secret
neutrophil
modul
major
injuri
support
find
patient
ard
product
oxid
damag
hydrogen
peroxid
h
exhal
breath
myeloperoxidas
oxid
aat
bal
cell
injuri
death
type
pneumocyt
like
occur
via
two
mechan
lipopolysaccharid
lp
induc
caspasedepend
apoptosi
hyperoxiainduc
cell
death
apoptosi
nonapoptot
mechan
former
lp
immunogen
compon
outer
membran
gramneg
bacteria
may
trigger
innat
immun
inflammatori
respons
via
tolllik
receptor
bind
fasassoci
death
domain
protein
lead
epitheli
cell
death
hyperoxiainduc
cell
death
hyperoxia
may
induc
express
angiopoietin
lung
epitheli
cell
angiogen
growth
factor
activ
caspas
pathway
lead
apoptot
cell
death
cell
death
ard
limit
mechan
studi
mani
pathway
occur
need
lymphangioleiomyomatosi
lam
rare
system
diseas
women
usual
reproduct
year
averag
age
year
character
prolifer
abnorm
smooth
muscl
cell
give
rise
cyst
lung
abnorm
lymphat
abdomin
tumor
notabl
kidney
addit
sporad
case
denot
slam
lam
also
affect
women
tuber
sclerosi
denot
tsclam
genet
disord
variabl
penetr
associ
seizur
brain
tumor
cognit
impair
global
estim
indic
tsclam
may
much
preval
slam
though
least
suggest
tsclam
may
milder
clinic
cours
slam
clinic
lam
patient
usual
present
increas
short
breath
exert
obstruct
symptom
spontan
pneumothorac
chylou
effus
abdomin
mass
consist
either
angiomyolipoma
andor
lymphangiomyoma
chest
imag
studi
characterist
reveal
hyperinfl
flatten
diaphragm
thinwal
cystic
chang
mortal
year
onset
symptom
lam
appear
small
thinwal
cyst
cm
randomli
throughout
lung
figur
microscop
lam
lung
contain
diffus
infiltr
smooth
muscl
cell
predominantli
around
lymphat
vein
venul
notabl
one
find
smooth
muscl
cell
subpleur
hemosiderinladen
macrophag
adjac
field
macrophag
also
seen
bronchoalveolar
lavag
specimen
patient
hemosiderin
pigment
lung
thought
secondari
microhemorrhag
obstruct
vein
figur
smooth
muscl
cell
lam
react
antibodi
premelanosom
protein
melanosomelik
structur
also
found
lam
cell
suggest
cell
characterist
smooth
muscl
melanosom
lesion
cell
lam
smooth
musclelik
spindl
epithelioid
morpholog
cell
slam
tsclam
part
iv
molecular
patholog
human
diseas
clonal
popul
although
lack
featur
malign
molecular
studi
reveal
abnorm
lam
cell
prolifer
caus
mutat
one
two
gene
link
tuber
sclerosi
tuber
sclerosi
complex
two
gene
control
cell
growth
differenti
aktmammalian
target
rapamycin
mtor
signal
pathway
pathway
growth
factor
receptor
insulin
pdgf
receptor
becom
phosphoryl
appropri
ligand
bind
result
activ
downstream
effector
ultim
akt
gene
product
hamartin
tuberin
act
dimer
maintain
rheb
member
ra
famili
gdpload
state
via
statin
act
break
aktmtor
pathway
therebi
retard
protein
synthesi
cell
growth
lam
cell
lossoffunct
mutat
two
gene
remov
inhibit
lead
enhanc
rheb
activ
mtor
activ
raptor
subsequ
phosphoryl
downstream
molecul
result
uncontrol
cell
growth
angiogenesi
damag
lung
tissu
figur
abnorm
prolifer
lam
cell
thought
damag
lung
overproduct
matrix
metalloproteinas
mmp
degrad
connect
tissu
lung
architectur
destroy
alveolar
integr
result
cyst
format
air
trap
destruct
capabl
lam
cell
enhanc
secret
angiogen
factor
vegfc
thought
caus
prolifer
lymphat
channel
throughout
lung
sarcoidosi
multisystem
diseas
involv
lung
case
common
age
group
among
femal
unit
state
african
american
commonli
affect
caucasian
clinic
pictur
sarcoidosi
variabl
patient
present
system
symptom
includ
fatigu
weight
loss
fever
common
find
chest
imag
studi
bilater
hilar
lymph
node
enlarg
reticular
reticulonodular
focal
alveolar
opac
within
lung
parenchyma
pulmonari
sarcoidosi
character
granuloma
consist
activ
histiocyt
call
epithelioid
histiocyt
form
nodul
rang
size
micron
figur
unlik
infecti
granuloma
usual
contain
area
central
necrosi
granuloma
pulmonari
sarcoidosi
predominantli
nonnecrot
also
granuloma
sarcoidosi
follow
distribut
along
lymphat
includ
area
subpleur
along
interlobular
septa
around
bronchovascular
area
contain
bronchiol
branch
pulmonari
arteri
figur
granuloma
occur
much
commonli
upper
lobe
lead
predomin
upper
lobe
fibrosi
bronchiectasi
seen
longstand
sarcoidosi
despit
year
research
sarcoidosi
etiolog
remain
unknown
agre
diseas
probabl
result
environment
trigger
act
genet
suscept
host
genet
basi
sarcoidosi
suggest
studi
demonstr
famili
cluster
racial
variat
complex
inherit
pattern
diseas
suggest
one
gene
may
involv
sever
gene
major
histocompat
complex
mhc
region
genom
implic
cluster
short
arm
chromosom
encompass
human
leukocyt
antigen
hla
domain
hla
class
mhc
molecul
associ
sarcoidosi
class
allel
hla
class
ii
molecul
implic
suscept
includ
hladr
allel
gene
mhc
gene
thought
regul
suscept
sarcoidosi
includ
chemokin
macrophag
inflammatori
rant
environment
factor
implic
aerosol
therefor
environment
agent
mode
entri
lung
caus
granuloma
lung
similar
sarcoidosi
factor
divid
two
major
categori
includ
infecti
noninfecti
agent
mycobacteria
extens
studi
organ
howev
role
diseas
remain
controversi
due
difficulti
identifi
either
cultur
histochem
stain
sarcoid
tissu
recent
molecular
techniqu
abl
demonstr
mycobacteri
nucleic
acid
sarcoid
tissu
howev
even
studi
use
technolog
produc
consist
result
role
organ
diseas
requir
studi
immun
respons
sarcoidosi
two
major
featur
initi
event
lead
granuloma
format
ii
progress
granulomat
respons
either
resolut
fibrosi
format
granuloma
trigger
activ
tcell
antigenpres
dendrit
histiocyt
result
releas
proinflammatori
cytokin
chemokin
recruit
activ
prolifer
mononuclear
cell
predominantli
tcell
activ
tcell
predominantli
thelper
th
cell
releas
ifng
alveolar
macrophag
site
releas
tnfa
growth
factor
result
granuloma
format
alveol
characterist
morpholog
featur
diseas
second
phase
immunolog
respons
lead
either
resolut
diseas
persist
granuloma
fibrosi
less
well
character
ongo
granuloma
format
inflamm
may
result
persist
presenc
antigen
excess
synthesi
chemotact
factor
part
iv
molecular
patholog
human
diseas
persist
mononuclear
cell
within
granuloma
importantli
role
tcell
granuloma
secret
cytokin
attract
stimul
ultim
deactiv
fibroblast
respons
fibrosi
seen
chronic
diseas
balanc
profibrot
mediat
tgfb
insulinlik
growth
factori
plateletderiv
growth
factor
pdgf
antifibrot
mediat
ifng
probabl
dictat
natur
histori
sarcoidosi
lung
gene
involv
macrophagederiv
cytokin
chemokin
mediat
fibrosi
possibl
candid
underli
genet
caus
complic
diseas
pulmonari
alveolar
proteinosi
pap
rare
diseas
lung
character
accumul
surfact
alveolar
space
name
alveolar
proteinosi
lipoproteinosi
perhap
accur
phospholipoproteinosi
appli
equal
entiti
pap
take
three
form
clinic
congenit
ii
secondari
iii
idiopath
primari
pap
aris
previous
healthi
adult
median
age
diagnosi
approxim
year
maletofemal
ratio
clinic
present
variabl
usual
includ
insidi
onset
slowli
progress
dyspnea
dri
cough
symptom
respiratori
distress
includ
fatigu
club
howev
almost
onethird
patient
asymptomat
found
clinic
abnorm
chest
xray
secondari
form
pap
found
patient
environment
exposur
includ
fine
silica
aluminum
titanium
dioxid
kaolin
dust
also
secondari
pap
may
found
patient
malign
commonli
hematolog
malign
myelogen
leukemia
chest
imag
studi
idiopath
secondari
form
commonli
show
fine
diffus
featheri
nodular
infiltr
center
hilar
area
spare
peripher
region
chest
computer
tomograph
infiltr
may
geometrictyp
shape
sometim
refer
crazi
pave
promin
microscop
featur
idiopath
secondari
pap
fill
alveoli
fine
granular
period
acidschiffposit
diastaseresist
pasd
acellular
materi
figur
chapter
molecular
basi
pulmonari
diseas
materi
consist
phospholipid
surfact
protein
b
c
carbohydr
alveolar
macrophag
am
promin
foami
cytoplasm
commonli
seen
alveolar
septa
remark
normal
appear
alveolar
space
denser
solid
clump
pasdposit
materi
definit
patholog
differ
idiopath
secondari
form
pap
well
document
etiolog
two
adult
form
pap
well
studi
known
idiopath
variant
theori
pathogenesi
form
focus
abnorm
accumul
surfactantlik
materi
within
alveolar
space
sinc
regul
surfact
level
alveoli
depend
appropri
synthesi
recycl
catabol
two
oppos
hypothes
includ
overproduct
versu
decreas
degrad
materi
normal
host
surfact
essenti
maintain
low
surfac
tension
need
proper
alveolar
inflat
ga
exchang
critic
role
maintain
proper
composit
amount
surfact
alveoli
perform
two
cell
type
type
pneumocyt
alveolar
macrophag
type
pneumocyt
synthes
surfact
endoplasm
reticulum
golgi
store
lamellar
bodi
deliv
fuse
apic
plasma
membran
secret
surfact
airway
catabol
surfact
carri
type
pneumocyt
am
pap
evid
suggest
clearanc
surfact
decreas
first
clue
underli
mechan
defect
function
came
studi
reveal
knockout
mice
defici
granulocytemacrophag
colonystimul
factor
gmcsf
develop
lung
lesion
similar
patient
pap
rather
serendipit
find
prompt
explor
center
effect
diminish
gmcsf
might
cellular
function
subsequ
studi
human
pap
reveal
autoimmun
mechan
circul
neutral
antibodi
gmcsf
block
bind
gmcsf
receptor
depress
effect
gmcsf
am
neutral
antibodi
gmcsf
often
identifi
idiopath
variant
pap
howev
recent
antibodi
also
report
patient
secondari
pap
gene
control
mani
function
control
signal
pathway
initi
gmcsf
bind
one
pathway
mediat
transcript
factor
control
gene
involv
surfact
degrad
among
bactericid
function
anoth
transcript
factor
peroxisomeproliferatoractiv
receptor
g
pparg
also
part
pathway
activ
gmcsf
pparg
control
express
gene
involv
intracellular
lipid
metabol
am
patient
pap
defici
transcript
factor
correct
gmcsf
therapi
overal
lack
gmcsfiniti
signal
am
patient
pap
lead
inhibit
pparg
pathway
result
decreas
surfact
catabol
intracellular
lipid
metabol
accumul
surfact
alveoli
figur
pulmonari
hypertens
consist
group
distinct
diseas
whose
patholog
character
abnorm
destruct
repair
remodel
prolifer
compart
pulmonari
vascular
tree
includ
arteri
arteriol
capillari
vein
classif
diseas
undergon
number
revis
recent
revis
group
diseas
base
patholog
clinic
characterist
five
major
diseas
categori
current
classif
system
pulmonari
arteri
hypertens
pah
ii
pulmonari
hypertens
left
heart
diseas
iii
pulmonari
hypertens
associ
lung
diseas
andor
hypoxemia
iv
pulmonari
hypertens
due
chronic
thrombot
andor
embol
diseas
v
miscellan
caus
includ
sarcoidosi
histiocytosi
x
lymphangioleiomyomatosi
clinic
cours
patient
pulmonari
hypertens
begin
exert
dyspnea
progress
chest
pain
syncop
increas
mean
pulmonari
arteri
pressur
eventu
right
heart
failur
rate
clinic
progress
vari
among
patient
month
mani
year
treatment
diseas
focus
block
mediat
involv
pathogenesi
diseas
howev
current
therapi
rare
prevent
progress
diseas
lung
transplant
provid
hope
longterm
surviv
major
group
classif
pah
subdivid
famili
pah
idiopath
pah
pah
associ
condit
connect
tissu
diseas
hiv
congenit
heart
diseas
pah
secondari
drug
toxin
anorexigen
cocain
amphetamin
diseas
primari
patholog
local
predominantli
small
pulmonari
arteri
arteriol
howev
two
diseas
group
pulmonari
venoocclus
diseas
pulmonari
capillari
hemangiomatosi
involv
predominantli
compon
pulmonari
vasculatur
vein
capillari
respect
patholog
chang
seen
pulmonari
vessel
patient
primarili
reflect
injuri
repair
endothelium
earli
patholog
chang
includ
medial
hypertrophi
intim
fibrosi
narrow
obliter
vessel
lumen
follow
remodel
revascular
produc
prolifer
abnorm
endotheliallin
space
structur
known
plexogen
lesion
pathognomon
featur
pah
figur
sever
patholog
lesion
abnorm
vascular
structur
becom
dilat
angiomatoidlik
may
develop
featur
necrot
vascul
transmur
inflamm
fibrinoid
necrosi
though
exact
pathogenet
mechan
pah
remain
unknown
research
past
year
begun
offer
clue
famili
form
pah
femaletomal
preval
autosom
domin
inherit
pattern
low
penetr
genet
basi
found
germlin
mutat
gene
encod
bone
morphogenet
protein
receptor
type
mutat
account
approxim
famili
pah
patient
sporad
pah
approxim
mutat
identifi
famili
pah
result
loss
receptor
function
either
alter
transcript
gene
missens
nonsens
frameshift
alter
codon
rna
spice
mistak
mechan
singl
mutat
gene
induc
vascular
smooth
muscl
prolifer
decreas
apoptosi
complet
understood
like
involv
defect
signal
pathway
receptor
famili
cytokin
bmp
member
tgfb
superfamili
protein
play
role
growth
regul
mani
cell
includ
pulmonari
vasculatur
vascular
smooth
muscl
cell
lung
tgfb
signal
caus
prolifer
smooth
muscl
pulmonari
arteriol
signal
caus
inhibit
prolifer
cell
favor
apoptot
environ
signal
occur
activ
receptor
complex
lead
phosphoryl
activ
number
cytoplasm
mediat
notabl
smad
protein
mother
decapentapleg
smad
protein
especi
smad
smad
smad
complex
smad
transloc
nucleu
target
gene
transcript
induc
antiprolif
effect
cell
famili
pah
gene
mutat
may
lead
insuffici
protein
product
subsequ
decreas
protein
function
case
decreas
receptor
function
decreas
smad
protein
activ
decreas
antiprolif
effect
vascular
smooth
muscl
cell
imbal
proprolif
effect
tgfb
antiprolif
effect
bmp
result
format
vascular
lesion
pah
figur
despit
advanc
question
regard
pathogenesi
pah
remain
notabl
patient
mutat
develop
clinic
diseas
specul
gene
confer
suscept
second
hit
requir
develop
clinic
diseas
modifi
gene
environment
trigger
perhap
drug
viral
infect
pulmonari
vasculitid
present
diffus
pulmonari
hemorrhag
usual
caus
one
three
major
pulmonari
vascul
syndrom
wegen
granulomatosi
churgstrauss
syndrom
microscop
polyangi
three
diseas
similar
clinic
present
consider
overlap
patholog
featur
small
vessel
system
vasculitid
affect
lung
well
organ
notabl
kidney
wegen
granulomatosi
wg
unusu
diseas
affect
upper
lower
respiratori
tract
kidney
usual
present
year
age
slightli
common
men
women
clinic
present
depend
affect
organ
lung
involv
hemoptysi
major
present
symptom
chest
imag
studi
may
show
varieti
pattern
commonli
bilater
ground
glass
opac
mass
usual
lower
lobe
may
cavit
immunolog
test
peripher
blood
end
organ
tissu
help
reveal
characterist
immunofluoresc
stain
pattern
antineutrophil
cytoplasm
antibodi
anca
antibodi
target
two
substanc
proteinas
myeloperoxidas
mpo
present
either
blood
tissu
pattern
immunofluoresc
stain
cytoplasm
canca
perinuclear
panca
former
pattern
commonli
seen
wegen
granulomatosi
latter
commonli
seen
microscop
polyangi
churgstrauss
syndrom
css
css
system
disord
defin
presenc
asthma
peripher
blood
eosinophilia
system
vascul
similar
wg
usual
present
year
age
clinic
diagnosi
requir
histori
asthma
peripher
blood
eosinophilia
neuropathi
abnorm
chest
imag
studi
sinus
organ
involv
includ
heart
central
nervou
system
kidney
though
less
commonli
wg
gastrointestin
tract
skin
chest
imag
usual
show
patchi
multifoc
infiltr
mass
cavit
rare
laboratori
test
reveal
posit
panca
test
patient
microscop
polyangi
mpa
similar
wg
css
system
vascul
involv
lung
usual
present
fourth
fifth
decad
life
clinic
onset
usual
sudden
fever
weight
loss
myalgia
arthralgia
kidney
main
organ
involv
mpa
common
caus
pulmonaryren
syndrom
lung
involv
occur
approxim
patient
skin
upper
respiratori
tract
common
site
similar
wg
css
anca
test
help
posit
panca
patient
chest
imag
usual
show
bilater
infiltr
without
mass
similar
css
treatment
three
diseas
immunosuppress
glucocorticoid
cyclophosphamid
three
usual
respond
well
although
wg
greater
relaps
rate
treatment
either
css
mpa
patholog
wg
css
mpa
overlap
featur
acut
chronic
vascul
involv
mediumand
smallsiz
vessel
lung
inflammatori
cell
infiltr
destroy
blood
vessel
lymphocyt
neutrophil
area
fibrinoid
necrosi
seen
howev
wg
characterist
area
microabscess
lead
mass
geograph
necrosi
basophilia
scatter
multinucl
giant
cell
present
wellform
granuloma
seen
help
distinguish
vasculitid
infect
figur
similarli
patholog
css
distinguish
featur
earli
patholog
character
eosinophil
pneumonia
area
loos
form
granuloma
central
necrosi
contain
degener
eosinophil
figur
infiltr
predominantli
eosinophil
neutrophil
lymphocyt
plasma
cell
also
present
capillar
seen
wg
csg
mpa
three
hemosiderin
deposit
present
within
alveolar
macrophag
deposit
connect
tissu
interstitium
vessel
wall
pathogenesi
three
pulmonari
hemorrhag
syndrom
similar
mechan
diseas
kidney
gener
diseas
lung
kidney
repres
immunemedi
lesion
thought
earli
form
larger
area
geograph
necrosi
produc
masslik
nodul
found
lung
chapter
molecular
basi
pulmonari
diseas
necrot
vasculitid
immun
deposit
vessel
exhibit
presenc
anca
autoantibodi
myeloperoxidas
mpo
proteinas
compon
primari
granul
neutrophil
mpa
css
primarili
diseas
mpo
antibodi
wg
primarili
diseas
antibodi
mechan
anca
induc
known
may
part
autoimmun
respons
environment
exposur
earli
life
autoantibodi
inflict
damag
vessel
mechan
yet
complet
understood
one
theori
suggest
circul
anca
bind
mpo
surfac
neutrophil
initi
respiratori
burst
degranul
apoptosi
ro
proteas
releas
inflict
endotheli
tissu
damag
adjac
vessel
anca
bind
may
also
induc
releas
proinflammatori
cytokin
chemokin
tnfa
contribut
vascular
inflamm
second
theori
postul
circul
immun
complex
excess
anca
antigen
mpo
anca
autoantibodi
attach
vascular
endothelium
activ
complement
result
chemotaxi
adhes
inflammatori
cell
caus
cell
undergo
respiratori
burst
first
theori
releas
ro
proteas
caus
vascular
endotheli
damag
theori
import
rememb
mpo
also
present
monocyt
anca
autoantibodi
may
involv
monocyt
similar
way
releas
inflammatori
mediat
infecti
diseas
lung
common
caus
pulmonari
diseas
given
constant
exposur
lung
environ
variou
organ
capabl
caus
infect
includ
common
virus
bacteria
well
uncommon
fungi
parasit
protozoa
diagnosi
specif
etiolog
agent
challeng
given
similar
clinic
featur
mani
difficult
identifi
lung
tissu
brief
overview
defens
mechan
lung
use
protect
serv
introduc
patholog
lung
infect
lung
multipl
anatom
mechan
defend
invas
variou
pathogen
first
upper
nasal
caviti
respiratori
tract
serv
anatom
barrier
inhal
organ
ciliat
epithelium
tortur
caviti
sinus
screen
larg
organ
typic
larger
micron
particl
ventur
respiratori
tract
cough
reflex
upper
trachea
elicit
serv
expel
second
mucociliari
tree
upper
respiratori
tract
captur
organ
evad
two
mechan
bronchial
epithelium
contain
cilia
micron
length
extend
air
surfac
liquid
asl
asl
bilay
micron
thick
consist
lowviscos
wateri
lower
layer
cover
highviscos
gel
upper
layer
secret
adjac
goblet
cell
sticki
upper
layer
serv
trap
organ
coordin
beat
cilia
move
entrap
invad
mucociliari
escal
larynx
expector
present
secret
larg
airway
within
surfact
line
alveolar
wall
solubl
mediat
secret
variou
cell
mediat
includ
lysozym
lactoferrin
lyse
bacteria
inhibit
growth
defensin
cathelicidin
small
peptid
microbicid
properti
surfact
protein
alveolar
level
bind
microorgan
enhanc
phagocytosi
also
direct
bactericid
activ
major
cell
innat
immun
respons
lung
alveolar
macrophag
polymorphonuclear
leukocyt
pmn
neutrophil
phagocyt
destroy
bacteria
aureu
pneumonia
h
influenza
respiratori
burst
gener
nadph
oxidasedepend
ro
instanc
am
may
ingest
kill
organ
occur
organ
mycobacterium
spp
nocardia
spp
legionella
spp
abil
organ
continu
replic
within
part
iv
molecular
patholog
human
diseas
cellmedi
immun
requir
complet
elimin
patient
defect
nadph
oxidas
especi
prone
respiratori
infect
organ
aureu
nocardia
spp
aspergillu
spp
bronchial
epitheli
cell
import
innat
immun
secret
cytokin
molecul
includ
granulocytemacrophag
colonystimul
factor
gmcsf
molecul
attract
macrophag
well
neutrophil
inflammatori
cell
area
enhanc
inflammatori
respons
organ
bronchial
epitheli
cell
also
serv
import
role
recogn
pathogen
patternrecognit
receptor
prr
natur
killer
nk
cell
involv
innat
immun
respons
surfac
receptor
recogn
cell
infect
virus
rsv
influenza
parainfluenza
rhinoviru
nk
cell
releas
ifng
recruit
immun
cell
add
antivir
respons
dendrit
cell
tissu
histiocyt
posit
around
airway
lymphat
lung
recogn
pathogen
antigen
trigger
prolifer
amplif
antigenspecif
tcell
immun
respons
bridg
innat
immun
respons
adapt
immun
respons
especi
import
fungal
infect
mechan
mediat
tolllik
receptor
tlr
abl
distinguish
pathogen
selfcompon
trigger
cytokin
product
nfkb
express
costimulatori
molecul
necessari
tcell
activ
organ
evad
basic
innat
immun
lung
adapt
immun
mechan
encompass
humor
cellular
immun
mechan
humor
immun
import
defens
encapsul
bacteria
notabl
pneumonia
pyogen
bacteria
h
influenza
staphylococci
spp
resolut
infect
requir
product
igg
antibodi
organ
cellular
immun
especi
import
respiratori
viral
infect
influenza
rsv
cmv
varicella
also
opportunist
infect
virus
induc
tcell
respons
clear
lung
virus
within
day
post
infect
granuloma
common
inflammatori
respons
pathogen
foreign
materi
notabl
granulomat
infect
lung
due
mycobacteria
fungal
organ
activ
tcell
organ
lead
prolifer
differenti
tcell
cell
releas
ifng
cell
activ
lung
macrophag
form
epithelioid
macrophag
increas
abil
kill
microorgan
express
surfac
molecul
promot
celltocel
fusion
giant
cell
addit
activ
macrophag
result
releas
numer
cytokin
includ
ifng
tnfa
patient
defici
tcell
ifng
granuloma
format
poor
alter
patholog
pictur
infect
effect
obviou
nontubercul
mycobacteri
infect
numer
pattern
injuri
depend
immun
statu
host
pneumonia
broadli
categor
one
five
major
clinicopatholog
categori
includ
communityacquir
pneumonia
acut
atyp
ii
nosocomi
pneumonia
iii
aspir
pneumonia
lung
abscess
iv
chronic
pneumonia
v
pneumonia
immunocompromis
host
type
present
characterist
clinic
pattern
may
caus
sever
pathogen
treatment
mani
time
empir
first
categori
compris
communityacquir
pneumonia
cap
repres
major
lung
infect
receiv
medic
treatment
usual
outpati
basi
low
mortal
patient
hospit
infect
typic
comorbid
respons
organ
includ
respiratori
syncyti
viru
rsv
rhinoviru
parainfluenza
influenza
viru
bacteria
includ
mycoplasma
pneumonia
rickettsia
notabl
chlamydia
pneumonia
chlamydia
caus
term
atyp
pneumonia
clinic
cours
character
progress
onset
fever
without
chill
dri
cough
chest
imag
reveal
focal
infiltr
acut
typic
cap
present
abruptli
high
fever
chill
product
cough
radiograph
lobar
segment
consolid
common
pathogen
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
moraxella
catarrhali
second
categori
nosocomi
pneumonia
consist
infect
acquir
within
hospit
healthcar
associ
facil
infect
usual
found
patient
predispos
risk
factor
major
sourc
morbid
mortal
studi
report
mortal
rang
common
risk
factor
includ
respiratori
ventil
artifici
airway
nasogastr
tube
supin
posit
medic
alter
gastric
empti
respons
organ
includ
klebsiella
spp
legionella
spp
staphylococcu
aureu
pseudomona
aeruginosa
third
categori
includ
aspir
pneumonia
lung
abscess
infect
occur
set
patient
aberr
swallow
gag
reflex
allow
gastric
oral
content
airway
organ
necrosi
caviti
format
occur
includ
aureu
k
pneumonia
anaerob
oral
flora
mycobacteria
clinic
infect
may
acut
cours
fever
dyspnea
insidi
cours
mani
time
patient
first
present
lung
caviti
empyema
necrot
pneumonia
fourth
categori
chronic
pneumonia
includ
indol
infect
caus
local
masslik
lesion
otherwis
healthi
host
nocardia
actinomyc
spp
common
pathogen
mycobacteria
fungi
may
also
caus
pneumonia
fifth
categori
includ
pneumonia
occur
set
immunocompromis
patient
includ
number
organ
otherwis
would
act
pathogen
virus
cmv
hsv
fungi
aspergillosi
pneumocysti
pneumonia
bacterium
mycobacterium
avium
complex
streptococcu
pneumonia
streptococcu
pneumonia
gramposit
diplococcu
also
known
pneumococcu
diplococcu
pneumonia
common
caus
bacteri
pneumonia
infant
elderli
patient
alcohol
diabet
patient
immunosuppress
pneumonia
usual
present
abruptli
chill
cough
rustcolor
sputum
pleuriti
high
fever
tachycardia
tachypnea
characterist
gross
patholog
lobar
pneumonia
progress
red
acut
phase
gray
organ
phase
fibrin
pleuriti
common
eventu
organ
entrap
lung
parenchyma
fibrou
capsul
microscop
examin
reveal
abund
fibrin
neutrophil
extravas
red
blood
cell
within
alveolar
space
congest
capillari
hemophilu
influenza
hemophilu
influenza
gramneg
bacillu
inhabit
upper
respiratori
tract
caus
otiti
media
epiglott
mening
usual
enter
lung
aspir
hematogen
spread
six
serotyp
defin
base
capsular
antigen
type
b
common
caus
pneumonia
type
pneumonia
commonli
found
children
elderli
underli
chronic
lung
diseas
emphysema
cystic
fibrosi
bronchiectasi
patient
hiv
infect
alcohol
bacteri
pneumonia
usual
preced
viral
mycoplasma
infect
damag
mucociliari
element
airway
allow
colon
h
influenza
symptom
includ
fever
product
purul
cough
myalgia
incid
pneumonia
common
communityacquir
pneumonia
children
quit
low
due
advent
effect
vaccin
howev
increas
incid
nosocomi
infect
like
pneumococc
pneumonia
patholog
h
influenza
pneumonia
lobar
distribut
neutrophilicrich
infiltr
pleural
effus
necrosi
empyema
may
occur
uncommon
staphylococcu
aureu
staphylococc
pneumonia
caus
staphylococcu
aureu
gramposit
cocci
usual
spread
lung
blood
infect
site
often
skin
though
common
commun
pathogen
found
twice
frequent
pneumonia
hospit
patient
often
attack
elderli
patient
cf
aris
coinfect
influenza
viral
pneumonia
clinic
cours
character
high
fever
chill
cough
purul
bloodi
sputum
rapidli
progress
dyspnea
gross
patholog
commonli
reveal
acut
bronchopneumonia
pattern
figur
may
evolv
necrot
caviti
congest
redpurpl
lung
airway
contain
bloodi
fluid
thick
mucoid
secret
histolog
pattern
character
bronchopneumonia
spread
distal
small
airway
alveolar
space
figur
form
abscess
connect
pleural
surfac
may
result
empyema
treatment
organ
becom
increasingli
problemat
due
antibioticresist
strain
notabl
methicillinresist
aureu
legionella
pneumophila
legionella
gramneg
bacilli
found
predominantli
aquat
habitat
lake
river
pond
stand
pool
water
humidifi
water
outlet
may
sourc
approxim
air
condition
contain
bacilli
though
serogroup
legionella
identifi
caus
overwhelm
major
human
pneumonia
clinic
diseas
take
two
form
legionnair
diseas
name
outbreak
pneumonia
american
legion
convent
philadelphia
ii
pontiac
fever
selflimit
flulik
diseas
nonspecif
symptom
legionella
pneumonia
present
sever
infect
lung
chill
rigor
nonproduct
cough
progress
rapidli
system
symptom
nausea
vomit
diarrhea
lead
renal
failur
death
without
immedi
antibiot
therapi
infect
lung
remark
red
congest
appear
distend
fluid
microscop
pictur
reveal
fibrinopurul
exud
fill
alveolar
space
mix
necrot
cellular
infiltr
degener
neutrophil
monocyt
figur
hyalin
membran
may
form
peripheri
lesion
pleural
effus
consist
fibrinoser
exud
common
pseudomona
aeruginosa
pseudomona
aeruginosa
gramneg
bacillu
found
throughout
environ
airway
hospit
patient
usual
enter
bodi
disrupt
epitheli
surfac
cut
burn
therapeut
devic
mechan
ventil
intravascular
cathet
pneumonia
caus
organ
usual
found
intens
care
unit
hospit
burn
unit
patient
underli
chronic
lung
diseas
includ
cystic
fibrosi
emphysema
patient
prolong
hospit
patholog
necrosi
bronchopneumonia
pattern
usual
consist
area
congest
hemorrhag
surround
halo
tanwhit
consolid
figur
necrot
vascul
abund
organ
vessel
wall
seen
cavit
common
figur
treat
lung
heal
caviti
pneumatocel
may
appear
smoothwal
fibrou
cyst
gramneg
bacilli
gramneg
bacilli
klebsiella
pneumonia
acinetobact
variou
enterobacteriacea
spp
common
nosocomi
pathogen
similar
p
aeruginosa
pathogen
colon
oropharynx
usual
introduc
lung
inhal
aspir
oral
content
notabl
friedland
pneumonia
caus
k
pneumonia
common
caus
gramneg
bacteri
pneumonia
typic
occur
men
year
age
usual
set
alcohol
diabet
mellitu
chronic
lung
diseas
patient
produc
larg
amount
thick
bloodi
sputum
product
viscou
mucopolysaccharid
capsul
organ
present
sever
system
symptom
hypotens
gener
weak
patholog
pneumonia
similar
pseudomona
pneumonia
mark
cavit
abund
organ
microscop
examin
nocardia
spp
nocardiosi
lung
caus
nocardia
asteroid
gramposit
rod
found
soil
organ
matter
infect
common
immunocompromis
adult
patient
seen
set
pulmonari
alveolar
proteinosi
chronic
lung
diseas
mycobacteri
granulomat
diseas
affect
lung
clinic
cours
indol
usual
begin
week
patient
present
medic
therapi
cough
common
often
thick
purul
sputum
immunocompromis
set
fever
chill
dyspnea
hemoptysi
common
weight
loss
may
occur
diseas
progress
patholog
remark
suppur
abscess
format
multipl
caviti
fill
green
thick
pu
inflammatori
infiltr
consist
neutrophil
macrophag
abund
necrot
debri
epithelioid
histiocyt
giant
cell
within
wall
caviti
figur
empyema
pleura
involv
occur
major
case
mycoplasma
rickettsia
pneumonia
mycoplasma
pneumonia
pneumonia
among
common
infect
lower
respiratori
tract
usual
occur
small
epidem
close
popul
often
present
atyp
featur
progress
onset
fever
without
chill
dri
cough
diffus
crackl
physic
examin
chest
imag
studi
reveal
patchi
interstiti
infiltr
patholog
featur
result
attach
organ
bronchiolar
epithelium
caus
epitheli
injuri
ulcer
secret
peroxid
case
sever
infect
diffus
alveolar
damag
may
present
chlamydi
pneumonia
chlamydia
spp
caus
pneumonia
varieti
clinic
set
chlamydia
trachomati
infect
found
predominantli
postnat
period
chlamydia
psittaci
result
direct
transmiss
infect
bird
includ
parakeet
parrot
pigeon
chlamydia
pneumonia
common
three
frequent
caus
communityacquir
pneumonia
typic
caus
mild
asymptomat
infect
fever
sore
throat
nonproduct
cough
cours
infect
may
sever
elderli
chest
imag
studi
show
alveolar
infiltr
pleural
effus
present
major
case
patholog
well
defin
sinc
infect
usual
selflimit
howev
experiment
anim
model
neutrophil
respons
earli
stage
interstiti
peribronchiolar
perivascular
infiltr
lymphocyt
macrophag
plasma
cell
latter
stage
infect
mycobacteria
major
caus
lung
infect
nonmotil
aerob
catalaseproduc
acidfast
bacilli
clinic
signific
lung
infect
caus
tuberculosi
group
nontubercul
mycobacteria
ntm
latter
group
consist
speci
three
caus
overwhelm
major
pulmonari
diseas
aviumintracellular
avium
complex
kansasii
fortuitumchelona
throughout
histori
tuberculosi
infect
tuberculosi
major
diseas
caus
organ
respons
worldwid
morbid
mortal
howev
past
two
decad
lung
diseas
caus
ntm
becom
much
common
repres
major
pulmonari
mycobacteri
diseas
mycobacterium
tuberculosi
pulmonari
tuberculosi
spread
interperson
contact
aerosol
droplet
alveoli
bacteria
caus
cellmedi
inflammatori
respons
capabl
induc
granuloma
format
necrosi
infect
extent
diseas
function
host
immun
respons
suscept
part
iv
molecular
patholog
human
diseas
patient
certain
condit
includ
immunosuppress
diabet
malign
renal
failur
among
other
clinic
infect
patient
product
cough
fever
weight
loss
may
develop
hemoptysi
cavit
progress
erod
pulmonari
vessel
extens
involv
lung
produc
signific
dyspnea
pleurit
chest
pain
patholog
tuberculosi
primarili
granuloma
format
acut
pneumonia
granuloma
predominantli
necrot
pneumonia
usual
contain
abund
fibrin
neutrophil
fill
alveolar
space
gross
lesion
refer
caseou
cheeselik
amount
necrosi
present
caseou
materi
extend
airway
commonli
cough
activ
diseas
chronic
form
diseas
area
undergo
fibrosi
involut
firm
hard
scar
three
major
clinicopatholog
variant
diseas
primari
tuberculosi
ii
postprimari
reactiv
tuberculosi
iii
progress
fibrocavitari
diseas
primari
tuberculosi
form
diseas
initi
site
infect
anywher
lung
usual
lower
lobe
anterior
segment
upper
lobe
area
receiv
ventil
lesion
usual
consist
dens
consolid
acut
pneumonia
necrot
granuloma
cavit
may
occur
especi
set
immunocompromis
host
foci
organ
may
spread
lymphat
elsewher
lung
hilar
lymph
node
bloodstream
lay
dormant
long
period
time
combin
primari
site
infect
involv
hilar
lymph
node
known
ghon
complex
postprimari
tuberculosi
form
tuberculosi
repres
reactiv
old
scar
primari
lesion
long
initi
insult
lesion
occur
anywher
lung
bacteria
primari
lesion
spread
usual
apic
consist
focu
organ
pneumonia
fibrosi
central
caseat
activ
lesion
typic
parenchym
pattern
acut
pneumonia
cavit
expand
includ
surround
lung
aggreg
granuloma
controversi
surround
lesion
aris
evid
suggest
lesion
repres
exogen
reinfect
patholog
reactiv
reinfect
may
indistinguish
although
reactiv
tuberculosi
may
appear
aris
fibrot
calcifi
chronic
lesion
progress
fibrocavitari
diseas
form
diseas
may
aris
either
primari
postprimari
tuberculosi
howev
latter
common
scenario
caviti
develop
form
diseas
begin
slowli
progress
necrot
pneumonia
abund
granuloma
figur
activ
diseas
may
spread
airway
caus
ulcer
necrosi
fibrosi
surround
bronchi
bronchiol
extens
diseas
way
depend
host
patient
depress
immun
system
larg
area
lung
involv
massiv
pulmonari
necrosi
usual
fibrou
capsul
develop
area
cavit
although
inspiss
necrot
materi
adjac
airway
remain
continu
sourc
inflamm
lead
reinfect
ongo
scar
nontubercul
mycobacteria
nontubercul
mycobacteria
ntm
ubiquit
inhabit
environ
isol
soil
fresh
brackish
water
hous
dust
bird
anim
food
increasingli
import
caus
pulmonari
diseas
current
ntm
speci
known
organ
thought
pathogen
lung
includ
clinic
present
lung
infect
vari
minim
symptomat
small
lesion
discov
routin
radiographi
sudden
hemoptysi
advanc
diseas
sever
cavit
tabl
two
characterist
lesion
diffus
infiltr
immunocompromis
patient
seen
commonli
hivposit
popul
virus
pulmonari
infect
due
virus
four
major
group
influenza
parainfluenza
respiratori
syncyti
viru
rsv
adenoviru
tabl
clinic
present
infect
common
featur
includ
insidi
onset
nonproduct
cough
fever
chest
pain
chest
imag
studi
usual
reveal
bilater
multifoc
infiltr
without
evid
cavit
pleural
involv
infect
mild
selflimit
requir
support
therapi
except
immunocompromis
host
clinic
cours
much
seriou
also
immunocompromis
patient
suscept
virus
herpesviru
cytomegaloviru
pneumonia
common
pathogen
normal
host
sinc
subset
pulmonari
viral
infect
emerg
much
aggress
clinic
cours
notabl
sar
coronaviru
hantaviru
virus
present
system
symptom
headach
myalgia
weak
follow
deterior
clinic
cours
respiratori
distress
shock
case
death
therapi
respiratori
viral
infect
support
although
antivir
avail
virus
mostli
use
set
immunocompromis
patient
ribavirin
guanosin
analogu
main
antivir
use
rsv
inhibitor
adamantan
amantadin
rimantadin
use
influenza
neuraminidas
inhibitor
oseltamivir
zanamivir
use
influenza
b
cytomegaloviru
treat
ganciclovir
foscarnet
cidofovir
herpesviru
treat
acyclovir
patholog
pattern
injuri
virus
similar
make
morpholog
distinct
among
difficult
howev
characterist
pattern
emerg
notabl
virus
caus
cytopath
chang
influenza
adenoviru
sar
coronaviru
hantaviru
caus
acut
lung
injuri
pattern
diffus
alveolar
damag
case
latter
two
virus
evid
hemorrhag
edema
influenza
adenoviru
also
caus
necrot
bronchiol
due
preferenti
infect
bronchial
epitheli
cell
final
viral
infect
distinguish
characterist
cytopath
inclus
adenoviru
identifi
characterist
smudg
cell
present
advanc
stage
diseas
repres
adenoviru
particl
nucleu
infect
cell
figur
cytomegaloviru
nuclear
owl
eye
inclus
well
cytoplasm
inclus
figur
herpesviru
glassi
intranuclear
inclus
also
multinucl
figur
fungi
larger
complex
bacteria
pattern
injuri
lung
differ
gener
destruct
pathogen
common
environ
enter
lung
inhal
though
mani
fungi
capabl
caus
pulmonari
diseas
inhabit
lung
colon
concern
caus
clinic
diseas
includ
endem
fungi
north
americahistoplasma
capsulatum
blastomyc
dermatitidi
coccidioid
immitisand
two
fungi
commonli
seen
immunocompromis
hostsaspergillu
fumigatu
pneumocysti
jiroveci
histoplasma
capsulatum
histoplasma
capsulatum
dimorph
fungu
preval
middl
portion
unit
state
great
lake
tennesse
fungu
present
soil
contamin
guano
debri
nest
bird
commonli
blackbird
chicken
bat
organ
live
environ
spore
conidia
germin
form
hypha
structur
divid
creat
yeast
form
inhal
induc
granuloma
format
lung
approxim
peopl
skin
test
posit
exposur
h
capsulatum
exposur
caus
clinic
diseas
diseas
typic
occur
peopl
expos
larg
amount
organ
construct
worker
move
larg
volum
dirt
spelunk
ventur
batridden
cave
acut
diseas
flulik
symptom
selflimit
heal
diseas
may
leav
behind
calcifi
granuloma
lung
appear
buckshot
chest
imag
studi
chronic
form
diseas
may
slowli
progress
give
rise
cavit
fibrou
lesion
immunocompromis
host
dissemin
histoplasmosi
seen
although
reactiv
uncommon
patholog
reveal
characterist
necrot
granuloma
distribut
around
airway
figur
contain
silverposit
yeast
form
micron
granuloma
may
resolv
scar
nodul
calcifi
produc
characterist
chest
imag
caviti
may
form
apic
progress
diseas
dissemin
form
diseas
abund
organ
within
macrophag
lung
throughout
mani
organ
bodi
blastomyc
dermatitidi
blastomyc
dermatitidi
also
endem
middl
unit
state
includ
ohio
mississippi
river
valley
found
wood
terrain
usual
wet
season
put
camper
outdoorsmen
risk
clinic
diseas
take
two
form
cutan
system
latter
begin
lung
inhal
acut
pulmonari
infect
take
nonspecif
form
fever
malais
chest
pain
imag
studi
may
show
either
infiltr
masslik
infiltr
thu
blastomyc
infect
may
mimic
diseas
diagnosi
may
delay
patient
go
chronic
diseas
cavit
progress
pulmonari
blastomycosi
manifest
acut
respiratori
distress
syndrom
cavitari
lesion
poor
prognosi
patholog
blastomyc
infect
similar
histoplasmosi
necrot
granuloma
howev
lesion
larger
show
neutrophil
necrosi
organ
also
larger
micron
promin
broadbas
bud
appar
routin
hematoxylin
eosin
stain
figur
coccidioid
immiti
coccidioid
immiti
found
semiarid
desert
climat
southwestern
unit
state
organ
inhal
spore
caus
acut
diseas
character
fever
chill
chest
pain
dyspnea
hemoptysi
chest
imag
studi
typic
show
consolid
cavit
hilar
lymphadenopathi
common
reactiv
dissemin
possibl
patient
previou
infect
whether
immunocompromis
patient
patholog
pulmonari
coccidioidomycosi
neutrophil
suppur
granulomat
organ
appear
larg
spherul
contain
endospor
visibl
silver
stain
spherul
micron
diamet
endospor
releas
surround
tissu
proceed
matur
new
spherul
figur
histoplasmosi
cavit
lesion
may
hyphal
form
begin
germin
aspergillu
fumigatu
aspergilli
asexu
myceli
fungi
ubiquit
environ
airborn
aspergillu
spore
weak
pathogen
produc
invas
infect
predominantli
immunocompromis
host
signific
chronic
lung
diseas
tissu
aspergilli
form
septat
hypha
micron
diamet
characterist
acuteangl
dichotom
branch
figur
organ
affect
lung
three
major
way
saprophyt
growth
bronchi
preexist
caviti
ii
allerg
hypersensit
reaction
predominantli
asthmat
iii
invas
aspergillosi
immunocompromis
host
saprophyt
aspergillu
produc
surfac
growth
minut
mass
hypha
usual
bronchiectat
caviti
emphysemat
bulla
scar
previou
lung
diseas
tuberculosi
sarcoidosi
patholog
usual
fibrouswal
caviti
contain
degener
hypha
figur
set
hypha
invad
lung
tissu
surfac
eros
vascular
caviti
may
caus
hemoptysi
aspergillu
caus
immunolog
respons
result
mucoid
impact
eosinophil
pneumonia
asthmat
entiti
known
allerg
bronchopulmonari
aspergillosi
abpa
patholog
one
see
mucoid
plug
superfici
eros
airway
histiocyt
inflamm
rare
hyphal
fragment
present
final
form
diseas
invas
pulmonari
aspergillosi
found
sever
immunocompromis
neutropen
patient
hypha
dissemin
blood
invad
blood
vessel
caus
thrombosi
hemorrhag
infarct
form
typic
targetoid
lesion
form
diseas
poor
prognosi
despit
aggress
antifung
therapi
pneumocysti
jiroveci
taxonomi
pneumocysti
jiroveci
formerli
pneumocysti
carinii
chang
past
decad
previous
thought
protozoan
base
histolog
characterist
trophozoit
cyst
life
form
recent
place
fungal
kingdom
ribosom
rna
found
sequenc
compat
ascomycet
fungi
inabl
cultur
pneumocysti
jiroveci
slow
understand
organ
anim
model
help
defin
antigen
genotyp
differ
among
variou
pneumocysti
organ
led
propos
speciesspecif
strain
p
jiroveci
found
human
infect
molecular
method
use
type
speci
examin
number
gene
loci
importantli
sequenc
analysi
thymidyl
synthas
ts
superoxid
dismutas
soda
gene
loci
epsp
synthas
domain
multifunct
arom
gene
mitochondri
small
subunit
ribosom
rna
mtssu
rrna
locu
use
distinguish
variou
pneumocysti
speci
infect
differ
mammalian
host
clinic
p
jiroveci
caus
diseas
predominantli
immunocompromis
set
pneumocysti
pneumonia
pcp
found
recent
time
commonli
aid
popul
prior
epidem
found
malnourish
infant
sever
immunocompromis
host
organ
cultur
diagnosi
pcp
continu
challeng
clinic
characterist
nonspecif
vari
patient
immun
statu
hiv
popul
patient
typic
develop
subacut
onset
progress
dyspnea
nonproduct
cough
malais
lowgrad
fever
nonhiv
popul
present
acut
fulmin
respiratori
failur
associ
cough
fever
usual
requir
mechan
ventil
chest
imag
studi
typic
show
bilater
symmetr
fine
reticular
interstiti
infiltr
involv
perihilar
area
spread
involv
entir
lung
figur
aspergillosi
aspergillu
fumigatu
grow
within
necrot
caviti
lung
branch
septat
fungal
hypha
seen
grocott
methenamin
silver
stain
figur
aspergilloma
fungal
hypha
aspergillu
fumigatu
colon
chronic
inflam
lung
caviti
may
grow
form
fungal
ball
dark
green
color
treat
surgic
resect
seen
case
lobectomi
specimen
treatment
usual
trimethoprimsulfamethoxazol
intraven
pentamidin
surviv
even
sever
immunocompromis
patient
life
cycl
p
jiroveci
consist
three
stage
trophozoit
cyst
sporozoit
trophozoit
form
adher
type
epithelium
replic
enlarg
three
precyst
stage
matur
cyst
form
found
alveolar
space
sporozoit
develop
within
immatur
cyst
meiosi
mitosi
matur
cyst
contain
eight
haploid
sporozoit
ruptur
cyst
wall
releas
sporozoit
surround
environ
matur
trophozoit
patholog
infect
predominantli
due
interact
organ
epithelium
attach
organ
lung
epithelium
via
glycoprotein
present
surfac
organ
bind
organ
type
cell
occur
via
surfac
receptor
type
cell
includ
macrophag
mannos
receptor
interact
glycoprotein
activ
pathway
organ
induc
gene
encod
pathway
induc
mate
prolifer
respons
format
pheromon
receptor
transcript
factor
heterotrimer
gprotein
subunit
addit
genet
effect
cyst
wall
contain
chitin
polym
substanc
particular
maintain
integr
induc
inflammatori
respons
host
wall
organ
stimul
releas
macrophag
reactiv
oxid
speci
gener
potent
proinflammatori
cytokin
tnfa
bind
organ
exert
toxic
effect
insid
macrophag
organ
incorpor
phagolysosom
degrad
tnfa
also
directli
recruit
inflammatori
cell
includ
neutrophil
lymphocyt
circul
monocyt
induc
releas
ifng
recruit
activ
inflammatori
cell
aggreg
recruit
inflammatori
cell
mediat
releas
respons
damag
lung
epithelium
endothelium
seen
diseas
patholog
pcp
typic
atyp
variant
typic
lung
contain
dens
interstiti
plasma
cell
pneumonia
expand
alveolar
wall
epithelium
consist
predominantli
type
pneumocyt
alveolar
space
contain
eosinophil
frothi
exud
contain
fine
hemoxylinstain
dot
repres
thicken
cyst
wall
figur
form
diseas
organ
abund
diagnosi
usual
made
bronchoalveolar
lavag
atyp
patholog
variant
includ
necrot
variant
pattern
similar
typic
form
exud
alveolar
infiltr
undergo
necrosi
caviti
format
caviti
heal
fibrouswal
cyst
similar
gross
appear
found
pseudomona
pneumonia
third
variant
wellform
granuloma
involv
airway
pattern
common
histoplasmosi
tuberculosi
form
organ
rare
difficult
find
even
tissu
organism
stain
gener
patholog
pattern
injuri
depend
host
immun
statu
typic
patholog
found
sever
immunocompromis
host
aid
popul
atyp
form
found
host
immun
system
less
compromis
pulmonari
langerhan
cell
histiocytosi
plch
erdheimchest
diseas
histiocyt
diseas
primarili
affect
lung
histiocyt
diseas
may
affect
lung
niemannpick
diseas
gaucher
diseas
hermanskypudlak
rosaidorfman
diseas
consid
primarili
lung
histiocyt
diseas
pulmonari
langerhan
cell
histiocytosi
plch
diseas
dendrit
histiocyt
lung
refer
langerhan
cell
lc
diseas
part
group
diseas
character
prolifer
langerhan
cell
organ
throughout
bodi
rang
malign
system
diseas
seen
children
pulmonari
variant
seen
adolesc
adult
plch
usual
result
inflammatori
neoplast
stimuli
lung
smoker
lung
involv
certain
neoplasm
chest
radiograph
patient
plch
usual
reveal
bilater
nodul
predominantli
upper
lobe
worrisom
metastat
diseas
treatment
involv
smoke
cessat
steroid
therapi
typic
diseas
undergo
spontan
regress
approxim
patient
progress
irrevers
endstag
fibrosi
patholog
plch
consist
airwaybas
lesion
prolifer
lc
earli
cellular
lesion
contain
mixtur
cell
includ
langerhan
cell
lymphocyt
plasma
cell
eosinophil
figur
though
previous
refer
eosinophil
granuloma
eosinophil
major
cell
type
present
lesion
best
loos
form
granuloma
immunohistochemistri
reveal
lc
diffus
strongli
immunoreact
protein
ultrastructur
analysi
reveal
intracytoplasm
organel
call
birbeck
granul
normal
constitu
langerhan
cell
greater
number
plch
pathogenet
mechan
plch
focu
defect
homeostasi
dendrit
cell
dc
lung
smoker
role
tobacco
smoke
may
play
stimul
prolifer
cell
studi
suggest
stimul
alveolar
macrophag
chemic
smoke
result
secret
cytokin
gmcsf
tgfb
tnfa
transgen
mice
accumul
dc
around
airway
may
result
excess
gmcsf
theori
suggest
cigarett
smoke
stimul
secret
bombesinlik
peptid
neuroendocrin
cell
bronchiolar
epithelium
lead
similar
stimul
alveolar
macrophag
cytokin
milieu
promot
proinflammatori
prolif
chang
smoker
get
plch
lead
suggest
smoker
underli
genet
suscept
develop
diseas
studi
establish
case
lc
plch
clonal
suggest
cellular
abnorm
must
play
part
pathogenesi
diseas
support
studi
shown
genet
mutat
allel
loss
tumor
suppressor
gene
smoker
plch
mechan
prolifer
lc
lead
destruct
bronchiolar
epithelium
observ
patholog
unclear
lc
normal
lung
littl
abil
interact
tcell
act
effect
antigenpres
cell
lc
plch
matur
immunophenotyp
express
costimulatori
molecul
need
lymphostimulatori
activ
whether
matur
immun
phenotyp
lead
unregul
immun
respons
destruct
bronchial
epitheli
cell
known
howev
studi
shown
bronchiolar
epitheli
cell
may
induc
express
matur
phenotyp
secret
cytokin
respons
environment
stimul
cigarett
smoke
viral
infect
develop
hyperplast
dysplast
lesion
express
new
foreign
antigen
erdheimchest
diseas
ecd
system
nonlangerhan
cell
histiocytosi
adult
commonli
involv
long
bone
involv
organ
includ
lung
report
lung
involv
occur
approxim
case
patient
usual
present
cough
dyspnea
rhonchi
pleurit
pain
radiograph
lung
reveal
infiltr
lymphat
distribut
predominantli
upper
lobe
promin
interstiti
septal
mark
mimic
sarcoidosi
pulmonari
involv
ecd
may
unfavor
prognosi
fibrosi
ensu
one
frequent
report
caus
death
treatment
ecd
variabl
corticosteroid
chemotherapi
surgic
resect
radiat
therapi
report
nonlangerhan
cell
histiocyt
dendrit
cell
phenotyp
main
cell
present
diseas
infiltr
contain
foami
histiocyt
scatter
giant
cell
scant
number
lymphocyt
plasma
cell
fibroblast
histiocyt
express
macrophag
antigen
factor
xiiia
dendrit
cell
antigen
express
protein
weakli
express
ultrastructur
analysi
reveal
phagolysosom
birbeck
granul
present
infiltr
involv
lung
usual
present
pleura
subpleura
within
interlobular
septa
around
bronchovascular
structur
remaind
lung
parenchyma
unremark
though
fibrosi
paracicatrici
emphysema
appear
late
stage
diseas
etiolog
ecd
known
rare
diseas
establish
primarili
macrophag
disord
histiocyt
abund
phagolysosom
express
antigen
consist
phagocyt
cell
like
close
relat
alveolar
macrophag
peripher
monocytosi
proinflammatori
cytokin
profil
found
patient
might
suggest
histiocyt
infiltr
result
system
monocyt
activ
invas
circul
monocyt
tissu
throughout
bodi
recent
ecd
patient
success
treat
agent
toxic
monocyt
support
theori
cell
play
part
diseas
altern
end
organ
cytokin
product
local
inflammatori
cell
result
prolifer
differenti
resid
immatur
histiocyt
popul
may
produc
similar
pictur
anoth
interest
observ
erdheimchest
report
occur
patient
langerhan
cell
histiocytosi
may
suggest
diseas
macrophag
transit
two
differ
phenotyp
along
differenti
spectrum
tissu
dendrit
cell
whether
benign
malign
prolifer
establish
patient
studi
clonal
demonstr
polymerasechain
reaction
environment
exposur
major
caus
lung
diseas
caus
wide
spectrum
acut
chronic
patholog
mani
organ
inorgan
materi
caus
lung
damag
similar
pattern
injuri
long
latent
period
difficult
isol
exact
offend
agent
without
thorough
clinic
histori
two
occup
lung
diseas
present
hereasbestosi
silicosisrepres
pneumoconiosi
defin
diseas
result
diffus
parenchym
lung
injuri
due
inhal
inorgan
materi
mani
patholog
pattern
injuri
depend
amount
length
time
exposur
also
caus
neoplast
diseas
lung
asbesto
fiber
natur
occur
silic
commonli
use
construct
materi
cement
insul
mani
textil
separ
two
group
base
mineralog
characterist
serpentin
fiber
name
long
curli
includ
chrysotil
asbesto
amphibol
fiber
straight
rodlik
includ
predominantli
amosit
crocidolit
asbesto
unit
state
asbesto
chrysotil
amphibol
pathogen
respons
neoplast
nonneoplast
pulmonari
diseas
associ
asbesto
exposur
definit
asbestosi
bilater
diffus
interstiti
fibrosi
lung
attribut
asbesto
exposur
diseas
mostli
affect
textil
construct
worker
usual
result
direct
exposur
year
latenc
clinic
diseas
invers
proport
level
exposur
symptom
gradual
onset
short
breath
cough
dri
rale
base
inspir
digit
club
earli
diseas
chest
xray
show
basilar
diseas
begin
predominantli
thicken
subpleur
progress
infiltr
fibrosi
involv
middl
zone
eventu
lead
thicken
airway
traction
bronchiectasi
apex
lung
usual
spare
clinic
find
nonspecif
consider
overlap
uip
diagnosi
usual
made
histori
signific
exposur
discov
gross
pictur
includ
bilater
lower
lobe
graytan
fibrosi
honeycomb
chang
late
diseas
microscop
asbestosi
caus
mani
pattern
injuri
lung
common
collagen
deposit
area
lymphat
fiber
highest
concentr
area
includ
subpleur
interlobular
septa
around
bronchovascular
area
contain
bronchiol
branch
pulmonari
arteri
hyalin
pleural
plaqu
common
manifest
asbesto
exposur
specif
asbesto
found
absenc
pulmonari
parenchym
diseas
eventu
fibrosi
involv
alveoli
beyond
bronchiol
caus
distort
lung
architectur
form
remodel
dilat
airspac
similar
seen
uip
distinguish
fibrosi
form
fibros
lung
diseas
difficult
presenc
ferrugin
bodi
asbesto
fiber
coat
iron
protein
mucopolysaccharid
coat
indic
signific
asbesto
exposur
support
diagnosi
figur
figur
asbestosi
cytopatholog
prepar
bronchoalveolar
lavag
specimen
illustr
asbesto
fiber
coat
ironproteinmucopolysaccharid
substanc
appear
golden
brown
bead
structur
known
ferrugin
bodi
silicosi
result
chronic
highdos
exposur
crystallin
silica
consist
silicon
oxygen
trace
amount
element
usual
iron
common
silica
quartz
present
larg
amount
rock
granit
shale
sandston
among
fibrogen
silica
type
thu
occup
risk
silicosi
includ
sandblast
quarri
stone
dress
foundri
work
exposur
quartz
high
diseas
take
three
major
clinic
patholog
form
differ
clinic
characterist
simpl
nodul
silicosi
mark
presenc
fine
nodul
cm
chest
imag
studi
usual
upper
lobe
patient
condit
typic
asymptomat
normal
respiratori
physiolog
patholog
lung
reveal
discret
hard
nodul
greengray
color
center
either
small
airway
subpleura
microscop
nodul
earli
stellat
shape
eventu
transform
whorl
appear
dustladen
macrophag
scatter
throughout
polar
light
examin
reveal
weakli
birefring
materi
complic
pneumoconiosi
repres
similar
patholog
find
larger
circumscrib
nodul
coalesc
larg
upper
lobe
mass
condit
known
progress
massiv
fibrosi
figur
patient
symptomat
product
cough
mix
pulmonari
function
test
reduc
diffus
capac
fibrosi
increas
diffus
interstiti
fibrosi
may
occur
howev
unlik
asbestosi
pattern
found
pneumoconiosi
complic
pneumoconiosi
found
rheumatoid
nodul
set
patient
rheumatoid
arthriti
known
caplan
syndrom
pathogenesi
asbestosi
silicosi
depend
upon
inflamm
fibrosi
caus
inhal
fiber
human
amount
fiber
need
caus
fibrosi
vari
person
person
may
relat
differ
fiber
deposit
base
size
lung
efficaci
lung
clear
fiber
studi
also
suggest
fiber
length
determin
amount
patholog
howev
associ
confirm
human
either
asbestosi
silicosi
diseas
known
factor
increas
risk
develop
diseas
exampl
smoker
exhibit
wors
diseas
nonsmok
similar
exposur
asbestosi
mechan
effect
unclear
although
specul
center
inhibit
fiber
clearanc
smoker
also
known
smoke
enhanc
uptak
fiber
pulmonari
epitheli
cell
way
may
increas
fibrogen
inflammatori
cytokin
product
cell
cellular
mechan
asbesto
silica
fiber
induc
inflamm
fibrosi
mediat
predominantli
alveolar
macrophag
case
silica
known
uptak
fiber
alveolar
macrophag
way
scaveng
receptor
express
surfac
cell
known
marco
macrophag
receptor
collagen
structur
insid
cell
fiber
activ
releas
ro
lead
cellular
molecular
damag
number
pathway
first
ro
directli
caus
lipid
peroxid
membran
damag
dna
damag
second
silicainduc
free
radic
trigger
phosphoryl
cellular
prolifer
pathway
mitogenactiv
protein
kinas
mapk
extracellular
signal
regul
kinas
erk
pathway
also
involv
prolifer
fibroblast
asbestosi
mesotheli
epitheli
cell
neoplast
diseas
associ
inhal
fiber
addit
fiber
activ
proinflammatori
pathway
control
transcript
factor
nuclear
nfkb
activ
protein
pathway
result
activ
earli
respons
gene
cfo
cjun
releas
proinflammatori
cytokin
well
fibrogen
factor
tnfa
tnfa
play
promin
role
diseas
regul
studi
anim
model
expos
silica
known
transcript
factor
label
nuclear
factor
activ
tcell
nfat
play
key
role
regul
tnfa
figur
complic
pneumoconiosi
progress
massiv
fibrosi
sagitt
cut
section
lung
reveal
larg
grayblack
mass
extend
apex
includ
major
lung
patient
long
histori
coal
mine
worker
microscop
section
reveal
abund
anthracot
pigment
scar
area
bind
site
nfat
found
promot
region
tnfa
gene
mediat
silicainduc
tnfa
transcript
probabl
via
h
atresia
lung
repres
prematur
closur
airway
level
bronchial
tree
includ
lobar
segment
subsegment
airway
clinic
children
usual
present
year
age
symptom
dyspnea
wheez
recurr
pneumonia
incident
find
chest
imag
studi
lesion
common
proxim
segment
bronchi
right
often
left
atresia
associ
anomali
vascular
suppli
affect
airway
lesion
repres
separ
aberr
segment
lung
known
sequestr
either
intralobar
extralobar
type
patholog
bronchial
atresia
sequestr
repres
sequela
chronic
inflamm
due
accumul
secret
blindend
airway
featur
consist
cystic
dilat
airway
mucu
parenchym
fibrosi
honeycomb
chang
intralobar
sequestr
il
anomal
vessel
muscular
arteri
enter
pleura
aortic
sourc
usual
thorac
area
il
separ
isol
area
lung
invest
normal
viscer
pleura
without
bronchial
arteri
connect
figur
extralobar
sequestr
el
pyramidshap
accessori
piec
lung
pleura
arteri
lung
without
airway
connect
categori
congenit
pulmonari
cystic
diseas
repres
major
congenit
pulmonari
diseas
includ
foregut
cyst
cystic
adenomatoid
malform
foregut
cyst
includ
bronchogen
esophag
thymic
cyst
form
defect
foregut
branch
clinic
cyst
usual
incident
find
chest
imag
studi
present
complic
due
infect
hemorrhag
patholog
featur
cyst
includ
subtl
differ
usual
appar
microscop
examin
grossli
cyst
usual
aris
proxim
either
within
mediastinum
proxim
region
lung
right
commonli
left
along
esophagu
rare
within
lung
parenchyma
diaphragm
microscop
cyst
contain
simpl
cuboid
columnar
epithelium
ciliat
noncili
may
undergo
squamou
metaplasia
distinguish
among
three
type
cyst
requir
presenc
element
bronchogen
cyst
submucos
gland
andor
hyalin
cartilag
within
wall
thymic
cyst
may
contain
residu
thymu
congenit
cystic
adenomatoid
malform
ccam
commonli
refer
congenit
pulmonari
airway
malform
cpam
segment
lung
immatur
airway
alveolar
parenchyma
usual
classifi
predomin
cyst
size
type
type
cyst
contain
main
larg
cyst
cm
common
cyst
distinguish
foregut
cyst
upon
recognit
cpam
immatur
alveolar
ductlik
structur
connect
surround
lung
parenchyma
type
cpam
also
notabl
known
undergo
malign
transform
usual
mucin
bronchioloalveolar
cell
adenocarcinoma
anomali
aris
due
defect
variou
stage
develop
best
consid
within
development
stage
embryon
stage
occur
within
first
week
life
ventral
wall
foregut
separ
trachea
esophagu
branch
form
left
right
lung
splanchnic
mesenchym
surround
foregut
form
vascular
connect
tissu
lung
defect
phase
result
complet
lack
lung
develop
known
pulmonari
agenesi
incomplet
separ
trachea
esophagu
caus
trachealesophag
atresia
fistula
pseudoglandular
stage
week
develop
time
rapid
develop
conduct
airway
includ
bronchi
bronchiol
expans
peripher
lung
acinar
bud
mesenchym
tissu
figur
intralobar
sequestr
tan
white
mass
involv
left
lower
lobectomi
specimen
repres
chronic
pneumonia
fibrosi
sequest
area
lung
dilat
airway
featur
endstag
fibrosi
commonli
found
entiti
part
iv
molecular
patholog
human
diseas
surround
bud
begin
thin
becom
vascular
form
cartilag
surround
proxim
branch
airway
canalicular
week
saccular
week
alveolar
week
matur
stage
develop
acinar
bud
continu
expand
mesenchym
surround
continu
thin
canalicular
stage
pulmonari
vascular
bed
begin
organ
distanc
blood
vascular
space
air
alveoli
narrow
respiratori
epithelium
begin
form
ga
exchang
unit
alveolu
becom
function
saccular
stage
differenti
respiratori
epithelium
includ
clara
cell
ciliat
noncili
cell
type
cell
first
product
surfact
occur
period
ga
exchang
unit
continu
matur
alveolar
stage
growth
septat
alveoli
process
continu
postnat
year
age
differ
type
cpam
aris
differ
stage
develop
cpam
result
defect
earli
embryon
pseudoglandular
stage
develop
produc
patholog
featur
primit
alveolar
bud
immatur
abnorm
airway
cartilag
structur
cpam
result
abnorm
format
distal
airway
pulmonari
parenchyma
canalicular
saccular
alveolar
phase
caus
patholog
immatur
alveolar
alveolar
simplif
enlarg
alveoli
variou
genet
defect
pathway
control
lung
morphogenesi
associ
congenit
lung
diseas
two
major
transcript
factor
respons
normal
branch
morphogenesi
first
thyroid
transcript
member
famili
hemeodomaincontain
transcript
factor
factor
play
role
lung
epithelialspecif
gene
express
proper
lung
bud
develop
embryon
stage
well
matur
respiratori
epithelium
second
major
factor
somat
hedgehog
shh
gli
express
endoderm
deriv
cell
requir
branch
morphogenesi
develop
lung
bud
foregut
endoderm
depend
appropri
express
lungspecif
gene
correct
time
develop
presenc
genet
defect
aberr
lung
develop
may
occur
exampl
mutat
variou
type
shhgli
gene
found
caus
tracheoesophag
fistula
anomal
pulmonari
vasculatur
aberr
airway
branch
also
delet
gene
associ
tracheoesophag
fistula
varieti
form
lung
dysgenesi
final
factor
present
surround
mesenchym
play
role
induc
proper
develop
pulmonari
endoderm
promin
mesenchym
factor
process
fibroblast
growth
factor
fgf
modul
proxim
distal
lung
branch
morphogenesi
delet
gene
may
caus
lung
agenesi
tracheal
malform
surfact
dysfunct
disord
repres
heterogen
group
inherit
disord
surfact
metabol
found
predominantli
infant
children
pulmonari
surfact
includ
phospholipid
surfact
protein
design
surfact
protein
b
c
spa
spb
spc
spd
synthes
secret
type
cell
begin
canalicular
stage
lung
develop
damag
type
cell
time
period
lead
acquir
surfact
defici
howev
commonli
defici
result
genet
defect
surfact
protein
major
diseas
caus
genet
defect
surfact
protein
b
sftpb
chromosom
surfact
protein
c
sftpc
chromosom
adenosin
triphosph
apt
bind
cassett
transport
subfamili
member
chromosom
defect
sftpb
autosom
recess
inherit
pattern
defect
sftpc
autosom
domin
pattern
spb
defici
common
present
birth
rapidli
progress
respiratori
failur
chest
imag
studi
show
diffus
ground
glass
infiltr
gross
patholog
lung
consist
heavi
red
congest
parenchyma
microscop
featur
rang
paplik
pattern
chronic
pneumon
infanc
cpi
pattern
spb
defici
pap
pattern
predomin
histolog
pictur
cuboid
alveolar
epithelium
eosinophil
pasposit
materi
within
alveolar
space
appear
diseas
progress
late
stage
diseas
alveolar
wall
thicken
chronic
inflammatori
infiltr
fibroblast
alveolar
proteinosistyp
pattern
injuri
confirm
immunohistochem
studi
establish
absenc
spb
within
surfactantlik
materi
diseas
due
sftpc
defici
may
present
within
week
birth
year
later
former
poor
prognosi
latter
variabl
prognosi
patient
surviv
adulthood
inde
spc
mutat
also
recogn
famili
caus
interstiti
pneumonia
pulmonari
fibrosi
adult
patholog
spc
defici
cpi
featur
less
proteinosi
contrast
abca
defici
either
pap
cpi
featur
former
present
earli
diseas
latter
present
chronic
affect
lung
spb
gene
sftpb
approxim
kb
length
locat
chromosom
recess
lossoffunct
mutat
associ
sftpb
gene
howev
common
mutat
gaa
substitut
c
codon
found
case
lack
spb
lead
abnorm
proport
phosphatidylglycerol
accumul
prospc
peptid
lead
alveolar
proteinosislik
patholog
spc
protein
defici
due
defect
sftpc
gene
local
human
chromosom
approxim
dominantli
express
mutat
sftpc
result
acut
chronic
lung
diseas
approxim
aris
spontan
remaind
inherit
common
mutat
threonin
substitut
isoleucin
codon
found
case
includ
sporad
inherit
diseas
mutat
lead
misfold
spc
protein
inhibit
progress
intracellular
secretori
pathway
usual
within
golgi
apparatu
endoplasm
reticulum
absenc
spc
within
alveolar
space
caus
sever
lung
diseas
mous
model
infant
document
mutat
prospc
protein
larger
primari
translat
product
spc
proteolyt
cleav
respiratori
distress
syndrom
rd
cpi
older
individu
patholog
pattern
observ
lung
mutat
includ
nonspecif
interstiti
pneumon
nsip
uip
affect
adult
popul
patholog
age
diseas
present
vari
even
within
famili
cohort
suggest
involv
second
hit
perhap
environment
factor
protein
member
famili
atpdepend
transport
includ
cftr
express
epitheli
cell
mutat
gene
result
sever
respiratori
failur
refractori
surfact
replac
cellular
basi
lack
surfact
patient
genet
mutat
known
presenc
abnorm
lamellar
bodi
within
type
cell
ultrastructur
analysi
suggest
disrupt
normal
surfact
synthesi
packag
diseas
evid
gene
contain
promot
share
element
consist
activ
transcript
factor
delet
either
gene
may
play
role
diseas
